{ "$schema_version": "5.3", "review_mode": "fresh", "claim_restatement": { "index_wording": "Senescence: Driver vs Byproduct", "entry_form": "phenomenon", "gradeable_restatement": "Accumulated senescent cells causally drive age-related organismal dysfunction, and selective removal of these cells extends mammalian lifespan or human healthspan.", "restatement_required": true, "split_into": [], "parent_claim": null, "scope_qualifiers": [ { "qualifier": "Species, genotype, baseline disease, diet, dose and timing", "determinable_before_outcome": true, "determined_from": "Enrollment and experimental design, before results; no responder-defined scope.", "action": "retained" } ] }, "hypothesis": { "name": "Senescence: Driver vs Byproduct", "central_claim": "Accumulated senescent cells causally drive age-related organismal dysfunction, and selective removal of these cells extends mammalian lifespan or human healthspan.", "proposed_mechanism": "Accumulated senescent cells causally drive age-related organismal dysfunction, and selective removal of these cells extends mammalian lifespan or human healthspan.", "claimed_scope": "Accumulated senescent cells causally drive age-related organismal dysfunction, and selective removal of these cells extends mammalian lifespan or human healthspan.", "claimed_level": [ "initiation", "progression" ], "is_conjunctive": true, "conjunctive_note": "Restate the topic as the causal-driver claim. Apply the index weakest-link rule to accumulation, causal dysfunction and intervention benefit; report causal-contribution and clinical sensitivities separately. A contribution is not universal primacy, and senescence markers are not unique cell identities." }, "rubric_routing": { "primary_rubric": "06-metabolism-aging.md", "secondary_rubrics": [ "05-immunology-inflammation.md" ], "index_notes_applied": [ "Restate the topic as the causal-driver claim. Apply the index weakest-link rule to accumulation, causal dysfunction and intervention benefit; report causal-contribution and clinical sensitivities separately. A contribution is not universal primacy, and senescence markers are not unique cell identities." ], "rubric_fit_note": "Exact archived v5.3 framework. Any stale index empirical framing is rechecked against primary results." }, "subclaim_matrix": { "subclaims": [ { "id": "SC1", "statement": "Senescent cells accumulate with normal age.", "subclaim_type": "existence", "scope": "normally aging mammalian tissues", "claimed_scope": "normally aging mammalian tissues", "governing_rubric": "06-metabolism-aging.md", "key_evidence_anchor": "Multi-marker, cell-resolved measurements rather than a single p16 signal", "hsef_level": "Β", "confidence": "Moderate", "governing_cap_or_threshold": "Quoted boundary and upward audit below.", "rationale": "Multimarker and cell-resolved studies support accumulation in defined aged tissues. This age relationship remains observational and p16 alone is not exclusive." }, { "id": "SC2", "statement": "Senescent cells are causally required for defined age-related dysfunction.", "subclaim_type": "necessity", "scope": "prespecified naturally aged mammalian tissues and functional phenotypes", "claimed_scope": "prespecified naturally aged mammalian tissues and functional phenotypes", "governing_rubric": "06-metabolism-aging.md", "key_evidence_anchor": "Selective timed clearance, lineage specificity, function and rescue", "hsef_level": "Ε", "confidence": "Moderate", "governing_cap_or_threshold": "Quoted boundary and upward audit below.", "rationale": "Selective adult clearance, transfer/clearance and orthogonal genetic/drug contrasts support causal contribution to defined mouse functions. Incomplete specificity, tissue-dependent harm and reporter concerns prevent universal necessity or systemic primacy." }, { "id": "SC3", "statement": "Senolytic intervention extends mammalian lifespan or human healthspan.", "subclaim_type": "application", "scope": "natural mammalian aging and prespecified human clinical populations", "claimed_scope": "natural mammalian aging and prespecified human clinical populations", "governing_rubric": "06-metabolism-aging.md", "key_evidence_anchor": "Survival and functional endpoints; species, cohorts, primary outcome and toxicity distinguished", "hsef_level": "Ε", "confidence": "Moderate", "governing_cap_or_threshold": "Quoted boundary and upward audit below.", "rationale": "The disjunction is met in constrained mouse lifespan/healthspan settings, including adult p16 and late-life p21 clearance. Human durable functional benefit is a separate Γ sensitivity, not a condition silently added to the registered mammalian-or-human claim." } ], "aggregation_rule": "weakest-link", "aggregation_preregistered": true, "aggregation_rationale": "Restate the topic as the causal-driver claim. Apply the index weakest-link rule to accumulation, causal dysfunction and intervention benefit; report causal-contribution and clinical sensitivities separately. A contribution is not universal primacy, and senescence markers are not unique cell identities.", "primary_subclaim_id": "SC2", "aggregation_derivation": "Preregistered weakest-link aggregation yields Β (SC1 Β, SC2 Ε, SC3 Ε). The causal-contribution sensitivity is Ε, not mere association. The application score acknowledges mouse survival and functional trajectories; human healthspan alone remains Γ. The bundled letter must not erase the causal contribution evidence or turn a real cellular state into a refuted phenomenon.", "aggregation_alternatives": { "weakest_link_would_return": "Β", "primary_subclaim_would_return": "Ε", "scope_matched_would_return": "Ε", "note": "Separate narrow successes do not replace the preregistered gate." }, "index_rule_deviation": "" }, "competing_models": { "models_evaluated": [ { "rank_in_tournament": 1, "model_id": "M2", "is_nominal": false, "name": "Context-dependent disease amplifier", "core_claim": "Specific persistent populations amplify tissue dysfunction while other states support repair.", "explains_what_nominal_does_not": "Specific persistent populations amplify tissue dysfunction while other states support repair.", "strongest_supporting_evidence": [ "Clearance/transfer contrasts and cell-type-specific harms converge on a mapped contextual effect." ], "strongest_contradictory_evidence": [ "This does not explain every upstream initiating lesion or the demographic rate of aging." ], "hsef_level_for_this_model": "Ε", "rationale": "Clearance/transfer contrasts and cell-type-specific harms converge on a mapped contextual effect. This does not explain every upstream initiating lesion or the demographic rate of aging." }, { "rank_in_tournament": 2, "model_id": "M4", "is_nominal": false, "name": "SASP-mediated dysfunction", "core_claim": "Secreted factors propagate harmful or reparative effects depending on duration and context.", "explains_what_nominal_does_not": "Secreted factors propagate harmful or reparative effects depending on duration and context.", "strongest_supporting_evidence": [ "Paracrine skin models, tissue transfer and SASP-linked phenotypes support local pathways." ], "strongest_contradictory_evidence": [ "Cell clearance does not isolate the secretome from structural and immune functions." ], "hsef_level_for_this_model": "Ε", "rationale": "Paracrine skin models, tissue transfer and SASP-linked phenotypes support local pathways. Cell clearance does not isolate the secretome from structural and immune functions." }, { "rank_in_tournament": 3, "model_id": "M5", "is_nominal": false, "name": "Immune-clearance failure", "core_claim": "Impaired surveillance and efferocytosis promote persistent cell states.", "explains_what_nominal_does_not": "Impaired surveillance and efferocytosis promote persistent cell states.", "strongest_supporting_evidence": [ "HLA-E/PD-L1 and aged TRM EP2 perturbations provide defined mechanistic support." ], "strongest_contradictory_evidence": [ "Immune metabolism and tissue injury also change; primary human immune-aging causation is not isolated." ], "hsef_level_for_this_model": "Ε", "rationale": "HLA-E/PD-L1 and aged TRM EP2 perturbations provide defined mechanistic support. Immune metabolism and tissue injury also change; primary human immune-aging causation is not isolated." }, { "rank_in_tournament": 4, "model_id": "M3", "is_nominal": false, "name": "Chronic repair or hyperfunction", "core_claim": "Persistent repair programs can become harmful after useful transient responses.", "explains_what_nominal_does_not": "Persistent repair programs can become harmful after useful transient responses.", "strongest_supporting_evidence": [ "Reparative lung niches and transient-versus-prolonged SASP exposure fit this model." ], "strongest_contradictory_evidence": [ "The origin of every senescent state is not a repair program." ], "hsef_level_for_this_model": "Γ", "rationale": "Reparative lung niches and transient-versus-prolonged SASP exposure fit this model. The origin of every senescent state is not a repair program." }, { "rank_in_tournament": 5, "model_id": "M1", "is_nominal": true, "name": "Systemic senescence primacy", "core_claim": "Senescent cells are the autonomous primary driver of organismal aging.", "explains_what_nominal_does_not": "Senescent cells are the autonomous primary driver of organismal aging.", "strongest_supporting_evidence": [ "Adult mouse clearance improves selected functions and survival." ], "strongest_contradictory_evidence": [ "Incomplete clearance, unchanged phenotypes, beneficial populations and human efficacy gaps block systemic primacy." ], "hsef_level_for_this_model": "Γ", "rationale": "Adult mouse clearance improves selected functions and survival. Incomplete clearance, unchanged phenotypes, beneficial populations and human efficacy gaps block systemic primacy." } ], "tournament_summary": "Descriptive comparison; does not modify the nominal score. Cell-type-resolved adult clearance with restoration of the targeted cell or its defined secretome would distinguish SASP-mediated amplification from structural loss and broad immune remodeling.", "study_separating_rank1_from_rank2": "Cell-type-resolved adult clearance with restoration of the targeted cell or its defined secretome would distinguish SASP-mediated amplification from structural loss and broad immune remodeling.", "nominal_wins_only_by_funding_artifact": false, "level_unchanged_by_tournament": true }, "evidence_inventory": [ { "n": 1, "pmid": "32555459", "title": "Senolytic CAR T cells reverse senescence-associated pathologies.", "citation": "Amor C, Feucht J, Leibold J et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature. 2020.", "doi": "10.1038/s41586-020-2403-9", "pmcid": "PMC7583560", "url": "https://pubmed.ncbi.nlm.nih.gov/32555459/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/32555459/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "ErratumIn: PMID38383793" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID32555459", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal immunotherapy", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "uPAR CAR-T cleared targeted cells and improved induced fibrosis or treated lung-cancer outcomes.", "what_it_does_not_show": "These are disease models, not normal-aging survival; a linked author correction remains to be resolved.", "confounders_present": [ "These are disease models, not normal-aging survival; a linked author correction remains to be resolved." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 2, "pmid": "26840489", "title": "Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan.", "citation": "Baker DJ, Childs BG, Durik M et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature. 2016.", "doi": "10.1038/nature16932", "pmcid": "PMC4845101", "url": "https://pubmed.ncbi.nlm.nih.gov/26840489/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/26840489/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "INK-ATTAC lineage, two natural-aging cohorts", "access_depth": "full_text_partial", "access_note": "Complete primary abstract and linked-status metadata examined. Selected body sections: 6:Discussion:paragraph0, 7:METHODS:paragraph0, 7:METHODS:paragraph1, 1:ATTAC clears senescent adipocyte progenitor cells, 2:Clearance by ATTAC is partial and tissue selective, 3:p16Ink4a-positive cells shorten lifespan and healthspan. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2", "SC3" ], "favors_models": [], "evidence_class": "Strong", "system": "animal genetic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Adult INK-ATTAC clearance extended median life in both sexes and two mouse backgrounds with selected organ benefits.", "what_it_does_not_show": "Body text shows partial tissue clearance, variable maximal survival and several unchanged functional endpoints; other p16-positive cells may be affected.", "confounders_present": [ "Body text shows partial tissue clearance, variable maximal survival and several unchanged functional endpoints; other p16-positive cells may be affected." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 3, "pmid": "29988130", "title": "Senolytics improve physical function and increase lifespan in old age.", "citation": "Xu M, Pirtskhalava T, Farr JN et al. Senolytics improve physical function and increase lifespan in old age. Nature medicine. 2018.", "doi": "10.1038/s41591-018-0092-9", "pmcid": "PMC6082705", "url": "https://pubmed.ncbi.nlm.nih.gov/29988130/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/29988130/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "Xu transfer and aged-DQ experiments", "access_depth": "full_text_partial", "access_note": "Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Results:paragraph15, 3:Online Methods:paragraph14, 1:Results:paragraph0, 1:Results:paragraph1, 1:Results:paragraph2, 1:Results:paragraph4, 1:Results:paragraph5, 1:Results:paragraph6. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal transfer and pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Senescent-cell transfer impaired function; clearance rescued and late-life DQ increased median remaining survival.", "what_it_does_not_show": "Artificial transferred burden is not normal initiation; 36% refers to post-treatment survival, not whole lifespan, and drug pleiotropy remains.", "confounders_present": [ "Artificial transferred burden is not normal initiation; 36% refers to post-treatment survival, not whole lifespan, and drug pleiotropy remains." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 4, "pmid": "22048312", "title": "Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders.", "citation": "Baker DJ, Wijshake T, Tchkonia T et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011.", "doi": "10.1038/nature10600", "pmcid": "PMC3468323", "url": "https://pubmed.ncbi.nlm.nih.gov/22048312/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/22048312/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "INK-ATTAC lineage, BubR1 cohort", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "INK-ATTAC clearance delayed selected pathologies in BubR1 progeroid mice, including late intervention.", "what_it_does_not_show": "A progeroid chromosome-checkpoint disorder does not represent the full spectrum of normal aging.", "confounders_present": [ "A progeroid chromosome-checkpoint disorder does not represent the full spectrum of normal aging." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 5, "pmid": "30279143", "title": "Fisetin is a senotherapeutic that extends health and lifespan.", "citation": "Yousefzadeh MJ, Zhu Y, McGowan SJ et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018.", "doi": "10.1016/j.ebiom.2018.09.015", "pmcid": "PMC6197652", "url": "https://pubmed.ncbi.nlm.nih.gov/30279143/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/30279143/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID30279143", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Late-life fisetin reduced markers and improved mouse health and survival.", "what_it_does_not_show": "Cell selectivity and drug pleiotropy limit causal attribution; human explants do not demonstrate clinical benefit.", "confounders_present": [ "Cell selectivity and drug pleiotropy limit causal attribution; human explants do not demonstrate clinical benefit." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 6, "pmid": "33526781", "title": "Calcium channel ITPR2 and mitochondria-ER contacts promote cellular senescence and aging.", "citation": "Ziegler DV, Vindrieux D, Goehrig D et al. Calcium channel ITPR2 and mitochondria-ER contacts promote cellular senescence and aging. Nature communications. 2021.", "doi": "10.1038/s41467-021-20993-z", "pmcid": "PMC7851384", "url": "https://pubmed.ncbi.nlm.nih.gov/33526781/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/33526781/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID33526781", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Itpr2 loss reduced senescence and improved mouse survival and metabolic phenotypes.", "what_it_does_not_show": "Calcium signalling and development are altered alongside senescence; clearance-mediated necessity is not isolated.", "confounders_present": [ "Calcium signalling and development are altered alongside senescence; clearance-mediated necessity is not isolated." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 7, "pmid": "36515093", "title": "Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression.", "citation": "Born E, Lipskaia L, Breau M et al. Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression. Circulation. 2023.", "doi": "10.1161/CIRCULATIONAHA.122.058794", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/36515093/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/36515093/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID36515093", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic and pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "contradicts", "what_it_shows": "Several clearance strategies worsened pulmonary vascular remodeling and endothelial loss in defined models.", "what_it_does_not_show": "Harm maps cell type and disease context, not absence of all beneficial senolytic effects.", "confounders_present": [ "Harm maps cell type and disease context, not absence of all beneficial senolytic effects." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 8, "pmid": "37913871", "title": "Transplanting old organs promotes senescence in young recipients.", "citation": "Iske J, Roesel MJ, Martin F et al. Transplanting old organs promotes senescence in young recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2024.", "doi": "10.1016/j.ajt.2023.10.013", "pmcid": "PMC10922683", "url": "https://pubmed.ncbi.nlm.nih.gov/37913871/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/37913871/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID37913871", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal transplantation", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Old-donor heart transplantation induced recipient dysfunction; donor senolysis reduced mtDNA release and improved physical outcomes.", "what_it_does_not_show": "Surgery and old-organ transfer are induced stressors; multiple donor changes complicate cell-specific mediation.", "confounders_present": [ "Surgery and old-organ transfer are induced stressors; multiple donor changes complicate cell-specific mediation." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 9, "pmid": "34873338", "title": "The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice.", "citation": "Xu Q, Fu Q, Li Z et al. The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice. Nature metabolism. 2021.", "doi": "10.1038/s42255-021-00491-8", "pmcid": "PMC8688144", "url": "https://pubmed.ncbi.nlm.nih.gov/34873338/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/34873338/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "ExpressionOfConcernIn: PMID41731120" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID34873338", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2", "SC3" ], "favors_models": [], "evidence_class": "Weak", "system": "animal pharmacologic", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "The PCC1 original report described improved old-mouse function and survival.", "what_it_does_not_show": "A 2026 editorial expression of concern identifies a similar control image and unavailable underlying raw data; no positive causal-threshold credit is assigned.", "confounders_present": [ "A 2026 editorial expression of concern identifies a similar control image and unavailable underlying raw data; no positive causal-threshold credit is assigned." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 10, "pmid": "37117524", "title": "Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice.", "citation": "Suda M, Shimizu I, Katsuumi G et al. Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice. Nature aging. 2021.", "doi": "10.1038/s43587-021-00151-2", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/37117524/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/37117524/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID37117524", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal immunotherapy", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "GPNMB ablation/vaccination improved selected mouse phenotypes and male progeroid survival.", "what_it_does_not_show": "Antigen specificity and premature-aging survival do not establish general human antiaging efficacy.", "confounders_present": [ "Antigen specificity and premature-aging survival do not establish general human antiaging efficacy." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 11, "pmid": "36637079", "title": "Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age.", "citation": "Islam MT, Tuday E, Allen S et al. Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age. Aging cell. 2023.", "doi": "10.1111/acel.13767", "pmcid": "PMC9924942", "url": "https://pubmed.ncbi.nlm.nih.gov/36637079/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/36637079/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID36637079", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "DQ reduced aged adipose inflammation and improved metabolic outcomes, with weaker liver/muscle marker effects.", "what_it_does_not_show": "Drug-mediated metabolism and cell elimination are incompletely separated; tissue responses are heterogeneous.", "confounders_present": [ "Drug-mediated metabolism and cell elimination are incompletely separated; tissue responses are heterogeneous." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 12, "pmid": "39658621", "title": "IL-23R is a senescence-linked circulating and tissue biomarker of aging.", "citation": "Carver CM, Rodriguez SL, Atkinson EJ et al. IL-23R is a senescence-linked circulating and tissue biomarker of aging. Nature aging. 2025.", "doi": "10.1038/s43587-024-00752-7", "pmcid": "PMC11839461", "url": "https://pubmed.ncbi.nlm.nih.gov/39658621/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/39658621/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID39658621", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1" ], "favors_models": [], "evidence_class": "Weak", "system": "animal biomarker and human observational", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "IL-23R and other circulating/tissue signals tracked age and responded to several clearance approaches.", "what_it_does_not_show": "A responsive biomarker does not uniquely count senescent cells or establish functional aging mediation.", "confounders_present": [ "A responsive biomarker does not uniquely count senescent cells or establish functional aging mediation." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 13, "pmid": "40253743", "title": "Senolytic treatment alleviates cochlear senescence and delays age-related hearing loss in C57BL/6J mice.", "citation": "Chen Y, Huang H, Luo Y et al. Senolytic treatment alleviates cochlear senescence and delays age-related hearing loss in C57BL/6J mice. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2025.", "doi": "10.1016/j.phymed.2025.156772", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/40253743/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/40253743/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID40253743", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "DQ delayed hearing decline in early-stage aging mice and modulated inflammatory signalling.", "what_it_does_not_show": "NF-kappa-B binding provides a plausible non-senolytic action; strain-specific hearing loss restricts inference.", "confounders_present": [ "NF-kappa-B binding provides a plausible non-senolytic action; strain-specific hearing loss restricts inference." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 14, "pmid": "41991686", "title": "p21+TREM2+ senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease.", "citation": "Salladay-Perez IA, Avila I, Estrada L et al. p21+TREM2+ senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease. Nature aging. 2026.", "doi": "10.1038/s43587-026-01101-6", "pmcid": "PMC13099426", "url": "https://pubmed.ncbi.nlm.nih.gov/41991686/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/41991686/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID41991686", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal and human tissue", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Multiomic p21/TREM2 macrophage profiling and senolysis linked a defined macrophage state to aged-liver dysfunction.", "what_it_does_not_show": "Human cirrhotic tissue is observational; macrophage activation and irreversible senescence need state-specific validation.", "confounders_present": [ "Human cirrhotic tissue is observational; macrophage activation and irreversible senescence need state-specific validation." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 15, "pmid": "39111286", "title": "Intermittent clearance of p21-highly-expressing cells extends lifespan and confers sustained benefits to health and physical function.", "citation": "Wang B, Wang L, Gasek NS et al. Intermittent clearance of p21-highly-expressing cells extends lifespan and confers sustained benefits to health and physical function. Cell metabolism. 2024.", "doi": "10.1016/j.cmet.2024.07.006", "pmcid": "PMC11315361", "url": "https://pubmed.ncbi.nlm.nih.gov/39111286/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/39111286/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "p21-Cre platform, late-life survival cohort", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Monthly p21-high cell clearance beginning at 20 months improved mouse function and median/maximal survival.", "what_it_does_not_show": "Marker-defined populations are heterogeneous; one mouse platform is not universal mammalian or human primacy.", "confounders_present": [ "Marker-defined populations are heterogeneous; one mouse platform is not universal mammalian or human primacy." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 16, "pmid": "34904366", "title": "Deletion of SA β-Gal+ cells using senolytics improves muscle regeneration in old mice.", "citation": "Dungan CM, Murach KA, Zdunek CJ et al. Deletion of SA β-Gal+ cells using senolytics improves muscle regeneration in old mice. Aging cell. 2022.", "doi": "10.1111/acel.13528", "pmcid": "PMC8761017", "url": "https://pubmed.ncbi.nlm.nih.gov/34904366/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/34904366/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID34904366", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "DQ enhanced old-muscle regeneration but blunted young-muscle regeneration after injury.", "what_it_does_not_show": "Age and repair timing determine effects; direct progenitor proliferation effects complicate senolysis mediation.", "confounders_present": [ "Age and repair timing determine effects; direct progenitor proliferation effects complicate senolysis mediation." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 17, "pmid": "41303716", "title": "Senolytic Treatment Improves Responsiveness to Mechanical Loading in the Skeleton of Aged Mice.", "citation": "Cunningham CJ, Kok HJ, Farr JN et al. Senolytic Treatment Improves Responsiveness to Mechanical Loading in the Skeleton of Aged Mice. International journal of molecular sciences. 2025.", "doi": "10.3390/ijms262211233", "pmcid": "PMC12653123", "url": "https://pubmed.ncbi.nlm.nih.gov/41303716/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/41303716/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID41303716", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "DQ improved aged tibial endocortical loading response but not aged ulnar periosteal response.", "what_it_does_not_show": "Bone surface, site and loading model define benefit; broad skeletal rejuvenation is unsupported.", "confounders_present": [ "Bone surface, site and loading model define benefit; broad skeletal rejuvenation is unsupported." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 18, "pmid": "40055369", "title": "Senescent-like microglia limit remyelination through the senescence associated secretory phenotype.", "citation": "Gross PS, Durán-Laforet V, Ho LT et al. Senescent-like microglia limit remyelination through the senescence associated secretory phenotype. Nature communications. 2025.", "doi": "10.1038/s41467-025-57632-w", "pmcid": "PMC11889183", "url": "https://pubmed.ncbi.nlm.nih.gov/40055369/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/40055369/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "UpdateOf: PMID38826296" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID40055369", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "null", "what_it_shows": "Senolytics improved remyelination in young/middle-aged but not aged mice; CCL11 impaired maturation.", "what_it_does_not_show": "Old-age nonresponse and injury context constrain translation; preprint and published update are not independent reports.", "confounders_present": [ "Old-age nonresponse and injury context constrain translation; preprint and published update are not independent reports." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 19, "pmid": "31542391", "title": "Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.", "citation": "Hickson LJ, Langhi Prata LGP, Bobart SA et al. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019.", "doi": "10.1016/j.ebiom.2019.08.069", "pmcid": "PMC6796530", "url": "https://pubmed.ncbi.nlm.nih.gov/31542391/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/31542391/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "ErratumIn: PMID31982828" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID31542391", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC3" ], "favors_models": [], "evidence_class": "Weak", "system": "human interventional", "decisive_perturbation": false, "endogenous": true, "direction": "supports", "what_it_shows": "Nine kidney-disease participants had lower skin/adipose marker burden after short DQ treatment.", "what_it_does_not_show": "Open-label biomarkers do not demonstrate renal functional benefit; linked corrigendum details remain unresolved.", "confounders_present": [ "Open-label biomarkers do not demonstrate renal functional benefit; linked corrigendum details remain unresolved." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 20, "pmid": "37679434", "title": "Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial.", "citation": "Gonzales MM, Garbarino VR, Kautz TF et al. Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial. Nature medicine. 2023.", "doi": "10.1038/s41591-023-02543-w", "pmcid": "PMC10875739", "url": "https://pubmed.ncbi.nlm.nih.gov/37679434/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/37679434/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "UpdateOf: PMID37162971" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID37679434", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC3" ], "favors_models": [], "evidence_class": "Weak", "system": "human interventional", "decisive_perturbation": false, "endogenous": true, "direction": "null", "what_it_shows": "Five AD participants completed feasibility treatment; dasatinib entered CSF but cognition/imaging did not significantly change.", "what_it_does_not_show": "Uncontrolled small safety study is not an efficacy trial; quercetin was undetectable in CSF.", "confounders_present": [ "Uncontrolled small safety study is not an efficacy trial; quercetin was undetectable in CSF." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 21, "pmid": "30616998", "title": "Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study.", "citation": "Justice JN, Nambiar AM, Tchkonia T et al. Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine. 2019.", "doi": "10.1016/j.ebiom.2018.12.052", "pmcid": "PMC6412088", "url": "https://pubmed.ncbi.nlm.nih.gov/30616998/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/30616998/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "IPF NCT02874989 open-label cohort", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC3" ], "favors_models": [], "evidence_class": "Weak", "system": "human interventional", "decisive_perturbation": false, "endogenous": true, "direction": "supports", "what_it_shows": "Open-label IPF feasibility study reported improved walking/gait/chair measures but unchanged lung function.", "what_it_does_not_show": "No placebo control and multiple secondary outcomes prevent attribution of human healthspan benefit.", "confounders_present": [ "No placebo control and multiple secondary outcomes prevent attribution of human healthspan benefit." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 22, "pmid": "38956196", "title": "Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial.", "citation": "Farr JN, Atkinson EJ, Achenbach SJ et al. Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial. Nature medicine. 2024.", "doi": "10.1038/s41591-024-03096-2", "pmcid": "PMC11705617", "url": "https://pubmed.ncbi.nlm.nih.gov/38956196/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/38956196/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "Bone NCT04313634", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "human interventional", "decisive_perturbation": true, "endogenous": true, "direction": "null", "what_it_shows": "The 60-person bone RCT missed its primary CTx endpoint and had transient secondary formation-marker changes.", "what_it_does_not_show": "High-p16 tertile benefits were exploratory; sustained clinical function and fracture reduction were not established.", "confounders_present": [ "High-p16 tertile benefits were exploratory; sustained clinical function and fracture reduction were not established." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [ "Reports use the same clinical cohort; separate report examination is not independent participant replication." ] }, { "n": 23, "pmid": "36857968", "title": "Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability.", "citation": "Nambiar A, Kellogg D, Justice J et al. Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability. EBioMedicine. 2023.", "doi": "10.1016/j.ebiom.2023.104481", "pmcid": "PMC10006434", "url": "https://pubmed.ncbi.nlm.nih.gov/36857968/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/36857968/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "IPF NCT02874989 separate randomized cohort", "access_depth": "full_text_partial", "access_note": "Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Methods, 2:Results. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "human interventional", "decisive_perturbation": true, "endogenous": true, "direction": "null", "what_it_shows": "The 12-person randomized IPF pilot completed dosing but showed no meaningful between-group functional signal.", "what_it_does_not_show": "Original Methods make feasibility/safety primary and report no multiplicity allowance; low power prevents definitive inefficacy inference.", "confounders_present": [ "Original Methods make feasibility/safety primary and report no multiplicity allowance; low power prevents definitive inefficacy inference." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 24, "pmid": "38321220", "title": "Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results.", "citation": "Crespo-Garcia S, Fournier F, Diaz-Marin R et al. Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results. Nature medicine. 2024.", "doi": "10.1038/s41591-024-02802-4", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/38321220/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/38321220/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID38321220", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal and human interventional", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "BCL-xL inhibition improved mouse diabetic retinal leakage; human phase 1 met safety objectives.", "what_it_does_not_show": "Safety and preclinical function do not establish randomized human efficacy or general healthspan.", "confounders_present": [ "Safety and preclinical function do not establish randomized human efficacy or general healthspan." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 25, "pmid": "39823170", "title": "Characterization of Human Senescent Cell Biomarkers for Clinical Trials.", "citation": "Farr JN, Monroe DG, Atkinson EJ et al. Characterization of Human Senescent Cell Biomarkers for Clinical Trials. Aging cell. 2025.", "doi": "10.1111/acel.14489", "pmcid": "PMC12073900", "url": "https://pubmed.ncbi.nlm.nih.gov/39823170/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/39823170/", "tier": "A", "source_tier": "A", "kind": "rct", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "Bone NCT04313634", "access_depth": "full_text_partial", "access_note": "Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Methods:paragraph8, 2:Results:paragraph2, 2:Results:paragraph5, 2:Results:paragraph6. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC3" ], "favors_models": [], "evidence_class": "Weak", "system": "human biomarker reanalysis", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "T-cell p16 variants and a SASP panel refined an exploratory bone-trial responder association.", "what_it_does_not_show": "Body text confirms reuse of the same trial and response-informed tertile analyses; this is not independent validation of efficacy.", "confounders_present": [ "Body text confirms reuse of the same trial and response-informed tertile analyses; this is not independent validation of efficacy." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [ "Reports use the same clinical cohort; separate report examination is not independent participant replication." ] }, { "n": 26, "pmid": "30913313", "title": "Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans.", "citation": "Farr JN, Rowsey JL, Eckhardt BA et al. Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2019.", "doi": "10.1002/jbmr.3729", "pmcid": "PMC6697189", "url": "https://pubmed.ncbi.nlm.nih.gov/30913313/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/30913313/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID30913313", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic and human tissue", "decisive_perturbation": true, "endogenous": false, "direction": "contradicts", "what_it_shows": "Clearing p16-positive cells did not rescue young-mouse ovariectomy bone loss; short human estrogen treatment did not change senescence markers.", "what_it_does_not_show": "Estrogen-deficiency bone loss is distinct from age-related bone loss and is a boundary rather than universal clearance failure.", "confounders_present": [ "Estrogen-deficiency bone loss is distinct from age-related bone loss and is a boundary rather than universal clearance failure." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 27, "pmid": "35974106", "title": "A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues.", "citation": "Saul D, Kosinsky RL, Atkinson EJ et al. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nature communications. 2022.", "doi": "10.1038/s41467-022-32552-1", "pmcid": "PMC9381717", "url": "https://pubmed.ncbi.nlm.nih.gov/35974106/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/35974106/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "SenMayo reused input cohorts; not independent efficacy", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1" ], "favors_models": [], "evidence_class": "Weak", "system": "human and animal profiling", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "SenMayo enrichment and single-cell analysis identified senescence-related tissue states and clearance-responsive panels.", "what_it_does_not_show": "Gene-set expression is not uniquely irreversible arrest or proof of mechanistic clinical benefit; some input cohorts are reused.", "confounders_present": [ "Gene-set expression is not uniquely irreversible arrest or proof of mechanistic clinical benefit; some input cohorts are reused." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 28, "pmid": "42462036", "title": "Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging.", "citation": "Tan YJ, Conley TE, Yao F et al. Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging. Science (New York, N.Y.). 2026.", "doi": "10.1126/science.aea3075", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/42462036/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/42462036/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID42462036", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic and pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "TRM EP2 reduction improved efferocytosis and multiple aged-mouse functional outcomes.", "what_it_does_not_show": "Macrophage metabolism and immune clearance are intertwined; human tissue associations do not prove human aging mediation.", "confounders_present": [ "Macrophage metabolism and immune clearance are intertwined; human tissue associations do not prove human aging mediation." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 29, "pmid": "17637672", "title": "Delayed ageing through damage protection by the Arf/p53 pathway.", "citation": "Matheu A, Maraver A, Klatt P et al. Delayed ageing through damage protection by the Arf/p53 pathway. Nature. 2007.", "doi": "10.1038/nature05949", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/17637672/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/17637672/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID17637672", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic", "decisive_perturbation": true, "endogenous": false, "direction": "contradicts", "what_it_shows": "Enhanced normally regulated Arf/p53 protected mice from damage and selected aging phenotypes.", "what_it_does_not_show": "Tumour-suppressor signalling has broad functions; suppressing every senescence program cannot be assumed beneficial.", "confounders_present": [ "Tumour-suppressor signalling has broad functions; suppressing every senescence program cannot be assumed beneficial." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 30, "pmid": "28230051", "title": "Cellular senescence mediates fibrotic pulmonary disease.", "citation": "Schafer MJ, White TA, Iijima K et al. Cellular senescence mediates fibrotic pulmonary disease. Nature communications. 2017.", "doi": "10.1038/ncomms14532", "pmcid": "PMC5331226", "url": "https://pubmed.ncbi.nlm.nih.gov/28230051/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/28230051/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID28230051", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic and pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Genetic and drug clearance improved function after bleomycin lung injury even when visible fibrosis remained.", "what_it_does_not_show": "Early injury-model intervention is not reversal of established human IPF or normal-aging initiation.", "confounders_present": [ "Early injury-model intervention is not reversal of established human IPF or normal-aging initiation." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 31, "pmid": "36147777", "title": "Characterization of cellular senescence in aging skeletal muscle.", "citation": "Zhang X, Habiballa L, Aversa Z et al. Characterization of cellular senescence in aging skeletal muscle. Nature aging. 2022.", "doi": "10.1038/s43587-022-00250-8", "pmcid": "PMC9491365", "url": "https://pubmed.ncbi.nlm.nih.gov/36147777/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/36147777/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID36147777", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal intervention and human tissue", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Multimodal profiling localized aged-muscle states and a senotherapeutic improved mouse strength.", "what_it_does_not_show": "Human tissue evidence remains observational; myofiber senescent-like states differ from proliferative-cell arrest.", "confounders_present": [ "Human tissue evidence remains observational; myofiber senescent-like states differ from proliferative-cell arrest." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 32, "pmid": "32485135", "title": "Defined p16High Senescent Cell Types Are Indispensable for Mouse Healthspan.", "citation": "Grosse L, Wagner N, Emelyanov A et al. Defined p16High Senescent Cell Types Are Indispensable for Mouse Healthspan. Cell metabolism. 2020.", "doi": "10.1016/j.cmet.2020.05.002", "pmcid": "", "url": "https://pubmed.ncbi.nlm.nih.gov/32485135/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/32485135/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID32485135", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic", "decisive_perturbation": true, "endogenous": false, "direction": "contradicts", "what_it_shows": "Knock-in p16-high clearance removed indispensable endothelial populations and worsened barriers, fibrosis and health.", "what_it_does_not_show": "Different reporter thresholds and cell coverage distinguish this system from INK-ATTAC; it does not negate all selected-cell clearance benefits.", "confounders_present": [ "Different reporter thresholds and cell coverage distinguish this system from INK-ATTAC; it does not negate all selected-cell clearance benefits." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 33, "pmid": "39103548", "title": "p16-dependent increase of PD-L1 stability regulates immunosurveillance of senescent cells.", "citation": "Majewska J, Agrawal A, Mayo A et al. p16-dependent increase of PD-L1 stability regulates immunosurveillance of senescent cells. Nature cell biology. 2024.", "doi": "10.1038/s41556-024-01465-0", "pmcid": "PMC11321988", "url": "https://pubmed.ncbi.nlm.nih.gov/39103548/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/39103548/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID39103548", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal and cellular perturbation", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "p16-mediated PD-L1 stabilization promoted persistence and Fc-engaging antibodies cleared defined populations.", "what_it_does_not_show": "Checkpoint-mediated clearance is a particular immune mechanism; global human aging causation remains untested.", "confounders_present": [ "Checkpoint-mediated clearance is a particular immune mechanism; global human aging causation remains untested." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 34, "pmid": "38816549", "title": "SGLT2 inhibition eliminates senescent cells and alleviates pathological aging.", "citation": "Katsuumi G, Shimizu I, Suda M et al. SGLT2 inhibition eliminates senescent cells and alleviates pathological aging. Nature aging. 2024.", "doi": "10.1038/s43587-024-00642-y", "pmcid": "PMC11257941", "url": "https://pubmed.ncbi.nlm.nih.gov/38816549/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/38816549/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID38816549", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2", "SC3" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Canagliflozin promoted clearance-related immune changes and extended progeroid mouse life.", "what_it_does_not_show": "Glucose, metabolism and immunosurveillance all change; normal human lifespan benefit cannot be assigned to senolysis.", "confounders_present": [ "Glucose, metabolism and immunosurveillance all change; normal human lifespan benefit cannot be assigned to senolysis." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 35, "pmid": "28608850", "title": "Cellular senescence drives age-dependent hepatic steatosis.", "citation": "Ogrodnik M, Miwa S, Tchkonia T et al. Cellular senescence drives age-dependent hepatic steatosis. Nature communications. 2017.", "doi": "10.1038/ncomms15691", "pmcid": "PMC5474745", "url": "https://pubmed.ncbi.nlm.nih.gov/28608850/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/28608850/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID28608850", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic and pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Clearance reduced hepatic fat and inducing hepatocyte senescence increased lipid accumulation.", "what_it_does_not_show": "Hepatic steatosis causality is narrower than organismal aging primacy; metabolic mediators remain multicomponent.", "confounders_present": [ "Hepatic steatosis causality is narrower than organismal aging primacy; metabolic mediators remain multicomponent." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 36, "pmid": "31633821", "title": "Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction.", "citation": "Victorelli S, Lagnado A, Halim J et al. Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction. The EMBO journal. 2019.", "doi": "10.15252/embj.2019101982", "pmcid": "PMC6885734", "url": "https://pubmed.ncbi.nlm.nih.gov/31633821/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/31633821/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID31633821", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Weak", "system": "human tissue and culture", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Aged melanocyte secretome caused paracrine telomere dysfunction and epidermal-model atrophy reversible by intervention.", "what_it_does_not_show": "Human skin sampling plus engineered culture is not an in vivo clinical aging-trajectory experiment.", "confounders_present": [ "Human skin sampling plus engineered culture is not an in vivo clinical aging-trajectory experiment." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 37, "pmid": "26657143", "title": "Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice.", "citation": "Chang J, Wang Y, Shao L et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nature medicine. 2016.", "doi": "10.1038/nm.4010", "pmcid": "PMC4762215", "url": "https://pubmed.ncbi.nlm.nih.gov/26657143/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/26657143/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID26657143", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "ABT263 cleared targeted populations and improved aged or irradiated stem-cell function.", "what_it_does_not_show": "BCL-family inhibitors affect other cells; radiation injury and natural aging are separate tested contexts.", "confounders_present": [ "BCL-family inhibitors affect other cells; radiation injury and natural aging are separate tested contexts." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 38, "pmid": "30907060", "title": "Targeting senescent cells alleviates obesity-induced metabolic dysfunction.", "citation": "Palmer AK, Xu M, Zhu Y et al. Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Aging cell. 2019.", "doi": "10.1111/acel.12950", "pmcid": "PMC6516193", "url": "https://pubmed.ncbi.nlm.nih.gov/30907060/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/30907060/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID30907060", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic and pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Genetic and drug clearance improved metabolic, renal and cardiac outcomes in obese mice.", "what_it_does_not_show": "Obesity-related dysfunction and normal-aging necessity are distinct scopes.", "confounders_present": [ "Obesity-related dysfunction and normal-aging necessity are distinct scopes." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 39, "pmid": "30232451", "title": "Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline.", "citation": "Bussian TJ, Aziz A, Meyer CF et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature. 2018.", "doi": "10.1038/s41586-018-0543-y", "pmcid": "PMC6206507", "url": "https://pubmed.ncbi.nlm.nih.gov/30232451/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/30232451/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID30232451", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "INK-ATTAC glial clearance prevented tau pathology, neuronal loss and cognitive decline in PS19 mice.", "what_it_does_not_show": "Preventive intervention in mutant-tau disease does not establish normal aging initiation or human senolytic efficacy.", "confounders_present": [ "Preventive intervention in mutant-tau disease does not establish normal aging initiation or human senolytic efficacy." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 40, "pmid": "28340339", "title": "Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging.", "citation": "Baar MP, Brandt RMC, Putavet DA et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. 2017.", "doi": "10.1016/j.cell.2017.02.031", "pmcid": "PMC5556182", "url": "https://pubmed.ncbi.nlm.nih.gov/28340339/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/28340339/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID28340339", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "FOXO4-p53 interfering peptide restored selected functions in naturally aged and stressed/progeroid mice.", "what_it_does_not_show": "Peptide specificity and disease rescue require independent replication before broad survival claims.", "confounders_present": [ "Peptide specificity and disease rescue require independent replication before broad survival claims." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 41, "pmid": "30612898", "title": "Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis.", "citation": "Ogrodnik M, Zhu Y, Langhi LGP et al. Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis. Cell metabolism. 2019.", "doi": "10.1016/j.cmet.2018.12.008", "pmcid": "PMC6509403", "url": "https://pubmed.ncbi.nlm.nih.gov/30612898/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/30612898/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "ErratumIn: PMID31067450" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID30612898", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic and pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Clearance restored neurogenesis and reduced anxiety-related behavior in obese mice.", "what_it_does_not_show": "Obesity-specific behavioral mechanisms and a linked erratum constrain broad interpretation.", "confounders_present": [ "Obesity-specific behavioral mechanisms and a linked erratum constrain broad interpretation." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 42, "pmid": "27341653", "title": "Identification of Senescent Cells in the Bone Microenvironment.", "citation": "Farr JN, Fraser DG, Wang H et al. Identification of Senescent Cells in the Bone Microenvironment. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2016.", "doi": "10.1002/jbmr.2892", "pmcid": "PMC5289710", "url": "https://pubmed.ncbi.nlm.nih.gov/27341653/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/27341653/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID27341653", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1" ], "favors_models": [], "evidence_class": "Weak", "system": "animal tissue profiling", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Aged bone lineages had elevated multiple markers, including osteocyte telomere damage and chromatin changes.", "what_it_does_not_show": "Cross-sectional multi-marker identity improves existence evidence but does not by itself show causal bone loss.", "confounders_present": [ "Cross-sectional multi-marker identity improves existence evidence but does not by itself show causal bone loss." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 43, "pmid": "33470505", "title": "Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice.", "citation": "Ogrodnik M, Evans SA, Fielder E et al. Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice. Aging cell. 2021.", "doi": "10.1111/acel.13296", "pmcid": "PMC7884042", "url": "https://pubmed.ncbi.nlm.nih.gov/33470505/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/33470505/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID33470505", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic and pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Genetic and DQ treatment reduced aged-microglial p16 state and improved mouse cognition.", "what_it_does_not_show": "Systemic and microglial effects are intertwined; aged-mouse cognition is not established human healthspan.", "confounders_present": [ "Systemic and microglial effects are intertwined; aged-mouse cognition is not established human healthspan." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 44, "pmid": "28436958", "title": "Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment.", "citation": "Jeon OH, Kim C, Laberge RM et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nature medicine. 2017.", "doi": "10.1038/nm.4324", "pmcid": "PMC5785239", "url": "https://pubmed.ncbi.nlm.nih.gov/28436958/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/28436958/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID28436958", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic and pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Post-traumatic joint clearance reduced pain/pathology and improved cartilage-related outcomes.", "what_it_does_not_show": "p16-3MR validation concerns require model-specific caution; orthogonal drug effects retain pleiotropy.", "confounders_present": [ "p16-3MR validation concerns require model-specific caution; orthogonal drug effects retain pleiotropy." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 45, "pmid": "31160572", "title": "Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition.", "citation": "Pereira BI, Devine OP, Vukmanovic-Stejic M et al. Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition. Nature communications. 2019.", "doi": "10.1038/s41467-019-10335-5", "pmcid": "PMC6547655", "url": "https://pubmed.ncbi.nlm.nih.gov/31160572/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/31160572/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID31160572", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Weak", "system": "human culture and tissue", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "HLA-E/NKG2A blockade enhanced immune recognition of cultured senescent cells; aged skin had higher HLA-E.", "what_it_does_not_show": "Culture immune killing and tissue association do not prove human systemic aging mediation.", "confounders_present": [ "Culture immune killing and tissue association do not prove human systemic aging mediation." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 46, "pmid": "27789842", "title": "Senescent intimal foam cells are deleterious at all stages of atherosclerosis.", "citation": "Childs BG, Baker DJ, Wijshake T et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science (New York, N.Y.). 2016.", "doi": "10.1126/science.aaf6659", "pmcid": "PMC5112585", "url": "https://pubmed.ncbi.nlm.nih.gov/27789842/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/27789842/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID27789842", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic and pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Clearance reduced atherosclerotic lesion development and instability-related phenotypes in Ldlr-null mice.", "what_it_does_not_show": "A lipid-driven disease model does not establish autonomous initiation of normal aging.", "confounders_present": [ "A lipid-driven disease model does not establish autonomous initiation of normal aging." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 47, "pmid": "30737259", "title": "Length-independent telomere damage drives post-mitotic cardiomyocyte senescence.", "citation": "Anderson R, Lagnado A, Maggiorani D et al. Length-independent telomere damage drives post-mitotic cardiomyocyte senescence. The EMBO journal. 2019.", "doi": "10.15252/embj.2018100492", "pmcid": "PMC6396144", "url": "https://pubmed.ncbi.nlm.nih.gov/30737259/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/30737259/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID30737259", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal intervention and human tissue", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Telomere damage marked post-mitotic cardiomyocyte states and clearance reduced mouse hypertrophy/fibrosis.", "what_it_does_not_show": "Reduced specific pathology does not demonstrate global rejuvenation; post-mitotic senescence identity needs multiple features.", "confounders_present": [ "Reduced specific pathology does not demonstrate global rejuvenation; post-mitotic senescence identity needs multiple features." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 48, "pmid": "39537987", "title": "Clearance of p21 highly expressing senescent cells accelerates cutaneous wound healing.", "citation": "Gasek NS, Yan P, Zhu J et al. Clearance of p21 highly expressing senescent cells accelerates cutaneous wound healing. Nature aging. 2025.", "doi": "10.1038/s43587-024-00755-4", "pmcid": "PMC12205026", "url": "https://pubmed.ncbi.nlm.nih.gov/39537987/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/39537987/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "p21-Cre platform, wound cohort", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Spatial profiling and p21-high clearance linked a wound-induced inflammatory population to slower closure.", "what_it_does_not_show": "This injury population differs from p16-high reparative cells and does not define all age-related senescence.", "confounders_present": [ "This injury population differs from p16-high reparative cells and does not define all age-related senescence." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 49, "pmid": "36227993", "title": "Sentinel p16INK4a+ cells in the basement membrane form a reparative niche in the lung.", "citation": "Reyes NS, Krasilnikov M, Allen NC et al. Sentinel p16INK4a+ cells in the basement membrane form a reparative niche in the lung. Science (New York, N.Y.). 2022.", "doi": "10.1126/science.abf3326", "pmcid": "PMC10621323", "url": "https://pubmed.ncbi.nlm.nih.gov/36227993/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/36227993/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID36227993", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic", "decisive_perturbation": true, "endogenous": false, "direction": "contradicts", "what_it_shows": "p16-positive niche fibroblasts promoted epithelial lung regeneration and p16 was functionally required.", "what_it_does_not_show": "Postnatal sentinel cells are a useful boundary, not necessarily the same state as chronic harmful senescent cells.", "confounders_present": [ "Postnatal sentinel cells are a useful boundary, not necessarily the same state as chronic harmful senescent cells." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 50, "pmid": "35024619", "title": "An inducible p21-Cre mouse model to monitor and manipulate p21-highly-expressing senescent cells in vivo.", "citation": "Wang B, Wang L, Gasek NS et al. An inducible p21-Cre mouse model to monitor and manipulate p21-highly-expressing senescent cells in vivo. Nature aging. 2021.", "doi": "10.1038/s43587-021-00107-6", "pmcid": "PMC8746571", "url": "https://pubmed.ncbi.nlm.nih.gov/35024619/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/35024619/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "p21-Cre platform", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Inducible p21-Cre captured aged marker-high populations and clearance improved old-mouse function.", "what_it_does_not_show": "Marker-defined targeting does not encompass all senescence; platform follow-ups are not independent system validation.", "confounders_present": [ "Marker-defined targeting does not encompass all senescence; platform follow-ups are not independent system validation." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 51, "pmid": "30773784", "title": "Elimination of senescent osteoclast progenitors has no effect on the age-associated loss of bone mass in mice.", "citation": "Kim HN, Chang J, Iyer S et al. Elimination of senescent osteoclast progenitors has no effect on the age-associated loss of bone mass in mice. Aging cell. 2019.", "doi": "10.1111/acel.12923", "pmcid": "PMC6516158", "url": "https://pubmed.ncbi.nlm.nih.gov/30773784/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/30773784/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID30773784", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic", "decisive_perturbation": true, "endogenous": false, "direction": "null", "what_it_shows": "p16-3MR clearance reduced osteoclast-progenitor markers but did not prevent age-related bone loss.", "what_it_does_not_show": "Osteocytes were not eliminated; the null cannot falsify unengaged osteocyte-mediated pathology and reporter validation is disputed.", "confounders_present": [ "Osteocytes were not eliminated; the null cannot falsify unengaged osteocyte-mediated pathology and reporter validation is disputed." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 52, "pmid": "38062873", "title": "Intermittent supplementation with fisetin improves arterial function in old mice by decreasing cellular senescence.", "citation": "Mahoney SA, Venkatasubramanian R, Darrah MA et al. Intermittent supplementation with fisetin improves arterial function in old mice by decreasing cellular senescence. Aging cell. 2024.", "doi": "10.1111/acel.14060", "pmcid": "PMC10928570", "url": "https://pubmed.ncbi.nlm.nih.gov/38062873/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/38062873/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID38062873", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal pharmacologic and ex vivo genetic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Fisetin improved old-mouse vascular function, with nonadditive ex vivo genetic clearance supporting a senolytic route.", "what_it_does_not_show": "Ex vivo nonadditivity is supportive rather than complete mediation; p16-3MR validation and drug pleiotropy limit certainty.", "confounders_present": [ "Ex vivo nonadditivity is supportive rather than complete mediation; p16-3MR validation and drug pleiotropy limit certainty." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 53, "pmid": "32341413", "title": "Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice.", "citation": "Cai Y, Zhou H, Zhu Y et al. Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice. Cell research. 2020.", "doi": "10.1038/s41422-020-0314-9", "pmcid": "PMC7184167", "url": "https://pubmed.ncbi.nlm.nih.gov/32341413/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/32341413/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID32341413", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "A beta-gal-activated prodrug reduced markers/inflammation and restored aged-mouse function.", "what_it_does_not_show": "Lysosomal activity is not senescence-exclusive and one pharmacologic platform does not establish broad specificity.", "confounders_present": [ "Lysosomal activity is not senescence-exclusive and one pharmacologic platform does not establish broad specificity." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 54, "pmid": "38753433", "title": "Osteochondroprogenitor cells and neutrophils expressing p21 and senescence markers modulate fracture repair.", "citation": "Saul D, Doolittle ML, Rowsey JL et al. Osteochondroprogenitor cells and neutrophils expressing p21 and senescence markers modulate fracture repair. The Journal of clinical investigation. 2024.", "doi": "10.1172/JCI179834", "pmcid": "PMC11178538", "url": "https://pubmed.ncbi.nlm.nih.gov/38753433/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/38753433/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "UpdateOf: PMID38370844" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "p21 fracture platform; published update", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal genetic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "p21-high clearance accelerated fracture repair but not aging bone loss; p16 clearance showed the converse boundary.", "what_it_does_not_show": "Distinct injury and aging states defeat a universal single-marker interpretation; published and preprint records are one study.", "confounders_present": [ "Distinct injury and aging states defeat a universal single-marker interpretation; published and preprint records are one study." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 55, "pmid": "34381212", "title": "Aged skeletal stem cells generate an inflammatory degenerative niche.", "citation": "Ambrosi TH, Marecic O, McArdle A et al. Aged skeletal stem cells generate an inflammatory degenerative niche. Nature. 2021.", "doi": "10.1038/s41586-021-03795-7", "pmcid": "PMC8721524", "url": "https://pubmed.ncbi.nlm.nih.gov/34381212/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/34381212/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID34381212", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal niche perturbation", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Aged skeletal stem-cell niche resisted youthful circulation; local BMP2/CSF1-antagonist combination restored regeneration.", "what_it_does_not_show": "A multifactorial niche intervention does not isolate senescent-cell burden as sole causal driver.", "confounders_present": [ "A multifactorial niche intervention does not isolate senescent-cell burden as sole causal driver." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 56, "pmid": "25499914", "title": "An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA.", "citation": "Demaria M, Ohtani N, Youssef SA et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Developmental cell. 2014.", "doi": "10.1016/j.devcel.2014.11.012", "pmcid": "PMC4349629", "url": "https://pubmed.ncbi.nlm.nih.gov/25499914/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/25499914/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "ExpressionOfConcernIn: PMID42412492" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID25499914", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Weak", "system": "animal genetic", "decisive_perturbation": false, "endogenous": false, "direction": "contradicts", "what_it_shows": "The original PDGF-AA report proposed reparative senescence and rescue of wound closure.", "what_it_does_not_show": "A linked 2026 expression of concern is present; detailed notice content was not obtained, so this paper receives no causal-threshold credit.", "confounders_present": [ "A linked 2026 expression of concern is present; detailed notice content was not obtained, so this paper receives no causal-threshold credit." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 57, "pmid": "39630941", "title": "Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing.", "citation": "Shvedova M, Thanapaul RJRS, Ha J et al. Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing. Aging. 2024.", "doi": "10.18632/aging.206165", "pmcid": "PMC11810067", "url": "https://pubmed.ncbi.nlm.nih.gov/39630941/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/39630941/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "UpdateOf: PMID39229113" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID39630941", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal pharmacologic", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Topical ABT263 primed old skin and accelerated later wound closure with transient inflammation.", "what_it_does_not_show": "Pretreatment and an induced local inflammatory response complicate attribution to cell removal alone.", "confounders_present": [ "Pretreatment and an induced local inflammatory response complicate attribution to cell removal alone." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 58, "pmid": "28143833", "title": "The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration.", "citation": "Ritschka B, Storer M, Mas A et al. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes & development. 2017.", "doi": "10.1101/gad.290635.116", "pmcid": "PMC5322731", "url": "https://pubmed.ncbi.nlm.nih.gov/28143833/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/28143833/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID28143833", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal and cellular perturbation", "decisive_perturbation": true, "endogenous": false, "direction": "contradicts", "what_it_shows": "Transient SASP exposure promoted regenerative plasticity whereas prolonged exposure induced arrest.", "what_it_does_not_show": "Exposure duration and injured tissues define scope; this is not a clinical senescent-cell delivery strategy.", "confounders_present": [ "Exposure duration and injured tissues define scope; this is not a clinical senescent-cell delivery strategy." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 59, "pmid": "15520862", "title": "Ink4a/Arf expression is a biomarker of aging.", "citation": "Krishnamurthy J, Torrice C, Ramsey MR et al. Ink4a/Arf expression is a biomarker of aging. The Journal of clinical investigation. 2004.", "doi": "10.1172/JCI22475", "pmcid": "PMC524230", "url": "https://pubmed.ncbi.nlm.nih.gov/15520862/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/15520862/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID15520862", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1" ], "favors_models": [], "evidence_class": "Weak", "system": "animal observational", "decisive_perturbation": false, "endogenous": false, "direction": "supports", "what_it_shows": "Ink4a/Arf increased in defined aged tissue compartments and correlated with pathology/CR responses.", "what_it_does_not_show": "Expression is a marker association, not an exclusive cell count or causal aging proof.", "confounders_present": [ "Expression is a marker association, not an exclusive cell count or causal aging proof." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 60, "pmid": "25754370", "title": "The Achilles' heel of senescent cells: from transcriptome to senolytic drugs.", "citation": "Zhu Y, Tchkonia T, Pirtskhalava T et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging cell. 2015.", "doi": "10.1111/acel.12344", "pmcid": "PMC4531078", "url": "https://pubmed.ncbi.nlm.nih.gov/25754370/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/25754370/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID25754370", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal pharmacologic and cellular", "decisive_perturbation": true, "endogenous": false, "direction": "supports", "what_it_shows": "Survival-network targeting identified cell-type-dependent DQ senolysis and improved selected mouse functions.", "what_it_does_not_show": "Different compounds target different cells; progeroid and radiation results must be separated from natural-aging benefit.", "confounders_present": [ "Different compounds target different cells; progeroid and radiation results must be separated from natural-aging benefit." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 61, "pmid": "28768895", "title": "p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli.", "citation": "Hall BM, Balan V, Gleiberman AS et al. p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli. Aging. 2017.", "doi": "10.18632/aging.101268", "pmcid": "PMC5611982", "url": "https://pubmed.ncbi.nlm.nih.gov/28768895/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/28768895/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID28768895", "access_depth": "full_text_partial", "access_note": "Complete primary abstract and linked-status metadata examined. Selected body sections: 1:RESULTS:paragraph3, 1:RESULTS:paragraph4, 1:RESULTS:paragraph5, 1:RESULTS:paragraph6. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC1", "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal and cellular perturbation", "decisive_perturbation": true, "endogenous": false, "direction": "contradicts", "what_it_shows": "Original Results show macrophage p16/beta-gal states respond reversibly to immune stimuli.", "what_it_does_not_show": "Single markers cannot uniquely identify irreversible senescence; this does not invalidate multi-marker ATTAC evidence wholesale.", "confounders_present": [ "Single markers cannot uniquely identify irreversible senescence; this does not invalidate multi-marker ATTAC evidence wholesale." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] }, { "n": 62, "pmid": "42209826", "title": "Limitations of the p16-3MR mouse model for detecting and eliminating senescent cells.", "citation": "Hori N, Kawamoto S, Uemura K et al. Limitations of the p16-3MR mouse model for detecting and eliminating senescent cells. EMBO reports. 2026.", "doi": "10.1038/s44319-026-00802-8", "pmcid": "PMC13354569", "url": "https://pubmed.ncbi.nlm.nih.gov/42209826/", "source_pointer": "https://pubmed.ncbi.nlm.nih.gov/42209826/", "tier": "A", "source_tier": "A", "kind": "primary", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID42209826", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "relates_to_subclaims": [ "SC2" ], "favors_models": [], "evidence_class": "Moderate", "system": "animal model validation", "decisive_perturbation": true, "endogenous": false, "direction": "contradicts", "what_it_shows": "A 2026 p16-3MR reevaluation failed to reproduce reporter and ablation performance with wild-type controls.", "what_it_does_not_show": "This targets a particular construct; INK-ATTAC is distinct, and an accompanying response exists but its substantive contents were unavailable.", "confounders_present": [ "This targets a particular construct; INK-ATTAC is distinct, and an accompanying response exists but its substantive contents were unavailable." ], "verification": "verified", "verification_note": "Bounded source attribution; not proof of the nominal mechanism.", "citation_context": { "retrieved": false, "supporting_count": 0, "mentioning_count": 0, "contrasting_count": 0, "notable_contrasting_statements": [] }, "shared_components": [] } ], "verification_summary": { "load_bearing_claims_checked": 66, "verified": 66, "unverified": 0, "contradicted": 0, "note": "Verified attribution is distinct from mechanism truth or complete body access." }, "factual_issues_found": [], "cap_rules_applied": [ { "subclaim_id": "SC1", "cap": "Β", "cap_source": "rubric", "triggered": true, "trigger_text_quoted": "Association with aging or age-related biomarkers without intervention-driven trajectory change caps at Β.", "specific_trigger": "Multimarker and cell-resolved studies support accumulation in defined aged tissues. This age relationship remains observational and p16 alone is not exclusive.", "resulting_ceiling": "Β" } ], "cap_precedence_resolutions": [ { "collision": "Perturbation in a defined setting versus broader inference", "subclaim_scope_cap_binds_on": "Accumulated senescent cells causally drive age-related organismal dysfunction, and selective removal of these cells extends mammalian lifespan or human healthspan.", "subclaim_scope_threshold_binds_on": "The precise experimentally tested subclaim scope", "resolution": "Β binds the existence/age relationship. Ε is assigned to causal contribution and application within experimentally mapped mouse contexts; the universal single-species cap still blocks broader organismal primacy and human inference. SC3 is explicitly disjunctive, so a demonstrated mouse survival effect cannot be downgraded solely because human efficacy remains unproved. Neither the reporter challenge nor the two concern notices negates all orthogonal evidence; flagged reports receive no positive causal-threshold credit.", "note": "Convergent lines are assessed as a set; one weak leg is not re-capped over the assembled case." } ], "boundary_check_BGD": [ { "subclaim_id": "SC1", "field_valid_perturbation_quote": "\n- Genetic or pharmacologic intervention producing reproducible lifespan/healthspan extension\n- Must separate developmental effects from true aging effects\n- Biomarker change alone does NOT satisfy this threshold", "qualifying_evidence_present": "no", "qualifying_evidence_citation": "PMID26840489, PMID41991686, PMID36147777, PMID32485135, PMID31633821, PMID30737259, PMID35024619, PMID28768895", "gamma_hard_rules_triggered": [ "Single markers do not identify every irreversible senescent state." ], "disease_phenotype_relevance": "yes", "perturbation_result_positive": "no", "perturbation_result_note": "Multimarker and cell-resolved studies support accumulation in defined aged tissues. This age relationship remains observational and p16 alone is not exclusive.", "ceiling_from_boundary_check": "Γ" }, { "subclaim_id": "SC2", "field_valid_perturbation_quote": "\n- Genetic or pharmacologic intervention producing reproducible lifespan/healthspan extension\n- Must separate developmental effects from true aging effects\n- Biomarker change alone does NOT satisfy this threshold", "qualifying_evidence_present": "yes", "qualifying_evidence_citation": "PMID32555459, PMID26840489, PMID29988130, PMID22048312, PMID30279143, PMID33526781, PMID36515093, PMID37913871, PMID37117524, PMID36637079, PMID40253743, PMID41991686, PMID39111286, PMID34904366, PMID41303716, PMID40055369, PMID38321220, PMID30913313, PMID42462036, PMID17637672, PMID28230051, PMID36147777, PMID32485135, PMID39103548, PMID38816549, PMID28608850, PMID31633821, PMID26657143, PMID30907060, PMID30232451, PMID28340339, PMID30612898, PMID33470505, PMID28436958, PMID31160572, PMID27789842, PMID30737259, PMID39537987, PMID36227993, PMID35024619, PMID30773784, PMID38062873, PMID32341413, PMID38753433, PMID34381212, PMID39630941, PMID28143833, PMID25754370, PMID28768895, PMID42209826", "gamma_hard_rules_triggered": [ "Broad single-species inference is capped; the scored contribution is restricted to tested mouse tissues and functions." ], "disease_phenotype_relevance": "yes", "perturbation_result_positive": "yes", "perturbation_result_note": "Selective adult clearance, transfer/clearance and orthogonal genetic/drug contrasts support causal contribution to defined mouse functions. Incomplete specificity, tissue-dependent harm and reporter concerns prevent universal necessity or systemic primacy.", "ceiling_from_boundary_check": "Δ or higher" }, { "subclaim_id": "SC3", "field_valid_perturbation_quote": "\n- Genetic or pharmacologic intervention producing reproducible lifespan/healthspan extension\n- Must separate developmental effects from true aging effects\n- Biomarker change alone does NOT satisfy this threshold", "qualifying_evidence_present": "yes", "qualifying_evidence_citation": "PMID26840489, PMID29988130, PMID30279143, PMID33526781, PMID37117524, PMID39111286, PMID38956196, PMID36857968, PMID38321220, PMID38816549", "gamma_hard_rules_triggered": [ "Mouse effects are contextual; no durable human healthy-life extension is established." ], "disease_phenotype_relevance": "yes", "perturbation_result_positive": "yes", "perturbation_result_note": "The disjunction is met in constrained mouse lifespan/healthspan settings, including adult p16 and late-life p21 clearance. Human durable functional benefit is a separate Γ sensitivity, not a condition silently added to the registered mammalian-or-human claim.", "ceiling_from_boundary_check": "Δ or higher" } ], "thresholds_tested": [ { "subclaim_id": "SC1", "threshold": "Δ", "requirement_quoted": "Requires at least one intervention changing lifespan or healthspan in a way consistent with the hypothesis.", "satisfied": "no", "supporting_evidence": [ "[2] Adult INK-ATTAC clearance extended median life in both sexes and two mouse backgrounds with selected organ benefits.", "[14] Multiomic p21/TREM2 macrophage profiling and senolysis linked a defined macrophage state to aged-liver dysfunction.", "[31] Multimodal profiling localized aged-muscle states and a senotherapeutic improved mouse strength.", "[32] Knock-in p16-high clearance removed indispensable endothelial populations and worsened barriers, fibrosis and health.", "[36] Aged melanocyte secretome caused paracrine telomere dysfunction and epidermal-model atrophy reversible by intervention.", "[47] Telomere damage marked post-mitotic cardiomyocyte states and clearance reduced mouse hypertrophy/fibrosis.", "[50] Inducible p21-Cre captured aged marker-high populations and clearance improved old-mouse function.", "[61] Original Results show macrophage p16/beta-gal states respond reversibly to immune stimuli." ], "what_would_cross_it": "Independent longitudinal cell-resolved multimarker validation improves the age relationship; a causal claim requires a separately stated perturbation subclaim." }, { "subclaim_id": "SC2", "threshold": "Δ", "requirement_quoted": "Requires at least one intervention changing lifespan or healthspan in a way consistent with the hypothesis.", "satisfied": "yes", "supporting_evidence": [ "[1] uPAR CAR-T cleared targeted cells and improved induced fibrosis or treated lung-cancer outcomes.", "[2] Adult INK-ATTAC clearance extended median life in both sexes and two mouse backgrounds with selected organ benefits.", "[3] Senescent-cell transfer impaired function; clearance rescued and late-life DQ increased median remaining survival.", "[4] INK-ATTAC clearance delayed selected pathologies in BubR1 progeroid mice, including late intervention.", "[5] Late-life fisetin reduced markers and improved mouse health and survival.", "[6] Itpr2 loss reduced senescence and improved mouse survival and metabolic phenotypes.", "[7] Several clearance strategies worsened pulmonary vascular remodeling and endothelial loss in defined models.", "[8] Old-donor heart transplantation induced recipient dysfunction; donor senolysis reduced mtDNA release and improved physical outcomes.", "[10] GPNMB ablation/vaccination improved selected mouse phenotypes and male progeroid survival.", "[11] DQ reduced aged adipose inflammation and improved metabolic outcomes, with weaker liver/muscle marker effects.", "[13] DQ delayed hearing decline in early-stage aging mice and modulated inflammatory signalling.", "[14] Multiomic p21/TREM2 macrophage profiling and senolysis linked a defined macrophage state to aged-liver dysfunction.", "[15] Monthly p21-high cell clearance beginning at 20 months improved mouse function and median/maximal survival.", "[16] DQ enhanced old-muscle regeneration but blunted young-muscle regeneration after injury.", "[17] DQ improved aged tibial endocortical loading response but not aged ulnar periosteal response.", "[18] Senolytics improved remyelination in young/middle-aged but not aged mice; CCL11 impaired maturation.", "[24] BCL-xL inhibition improved mouse diabetic retinal leakage; human phase 1 met safety objectives.", "[26] Clearing p16-positive cells did not rescue young-mouse ovariectomy bone loss; short human estrogen treatment did not change senescence markers.", "[28] TRM EP2 reduction improved efferocytosis and multiple aged-mouse functional outcomes.", "[29] Enhanced normally regulated Arf/p53 protected mice from damage and selected aging phenotypes.", "[30] Genetic and drug clearance improved function after bleomycin lung injury even when visible fibrosis remained.", "[31] Multimodal profiling localized aged-muscle states and a senotherapeutic improved mouse strength.", "[32] Knock-in p16-high clearance removed indispensable endothelial populations and worsened barriers, fibrosis and health.", "[33] p16-mediated PD-L1 stabilization promoted persistence and Fc-engaging antibodies cleared defined populations.", "[34] Canagliflozin promoted clearance-related immune changes and extended progeroid mouse life.", "[35] Clearance reduced hepatic fat and inducing hepatocyte senescence increased lipid accumulation.", "[36] Aged melanocyte secretome caused paracrine telomere dysfunction and epidermal-model atrophy reversible by intervention.", "[37] ABT263 cleared targeted populations and improved aged or irradiated stem-cell function.", "[38] Genetic and drug clearance improved metabolic, renal and cardiac outcomes in obese mice.", "[39] INK-ATTAC glial clearance prevented tau pathology, neuronal loss and cognitive decline in PS19 mice.", "[40] FOXO4-p53 interfering peptide restored selected functions in naturally aged and stressed/progeroid mice.", "[41] Clearance restored neurogenesis and reduced anxiety-related behavior in obese mice.", "[43] Genetic and DQ treatment reduced aged-microglial p16 state and improved mouse cognition.", "[44] Post-traumatic joint clearance reduced pain/pathology and improved cartilage-related outcomes.", "[45] HLA-E/NKG2A blockade enhanced immune recognition of cultured senescent cells; aged skin had higher HLA-E.", "[46] Clearance reduced atherosclerotic lesion development and instability-related phenotypes in Ldlr-null mice.", "[47] Telomere damage marked post-mitotic cardiomyocyte states and clearance reduced mouse hypertrophy/fibrosis.", "[48] Spatial profiling and p21-high clearance linked a wound-induced inflammatory population to slower closure.", "[49] p16-positive niche fibroblasts promoted epithelial lung regeneration and p16 was functionally required.", "[50] Inducible p21-Cre captured aged marker-high populations and clearance improved old-mouse function.", "[51] p16-3MR clearance reduced osteoclast-progenitor markers but did not prevent age-related bone loss.", "[52] Fisetin improved old-mouse vascular function, with nonadditive ex vivo genetic clearance supporting a senolytic route.", "[53] A beta-gal-activated prodrug reduced markers/inflammation and restored aged-mouse function.", "[54] p21-high clearance accelerated fracture repair but not aging bone loss; p16 clearance showed the converse boundary.", "[55] Aged skeletal stem-cell niche resisted youthful circulation; local BMP2/CSF1-antagonist combination restored regeneration.", "[57] Topical ABT263 primed old skin and accelerated later wound closure with transient inflammation.", "[58] Transient SASP exposure promoted regenerative plasticity whereas prolonged exposure induced arrest.", "[60] Survival-network targeting identified cell-type-dependent DQ senolysis and improved selected mouse functions.", "[61] Original Results show macrophage p16/beta-gal states respond reversibly to immune stimuli.", "[62] A 2026 p16-3MR reevaluation failed to reproduce reporter and ablation performance with wild-type controls." ], "what_would_cross_it": "" }, { "subclaim_id": "SC2", "threshold": "Ε", "requirement_quoted": "Requires causal effect in constrained contexts, backgrounds, or species.", "satisfied": "yes", "supporting_evidence": [ "[1] uPAR CAR-T cleared targeted cells and improved induced fibrosis or treated lung-cancer outcomes.", "[2] Adult INK-ATTAC clearance extended median life in both sexes and two mouse backgrounds with selected organ benefits.", "[3] Senescent-cell transfer impaired function; clearance rescued and late-life DQ increased median remaining survival.", "[4] INK-ATTAC clearance delayed selected pathologies in BubR1 progeroid mice, including late intervention.", "[5] Late-life fisetin reduced markers and improved mouse health and survival.", "[6] Itpr2 loss reduced senescence and improved mouse survival and metabolic phenotypes.", "[7] Several clearance strategies worsened pulmonary vascular remodeling and endothelial loss in defined models.", "[8] Old-donor heart transplantation induced recipient dysfunction; donor senolysis reduced mtDNA release and improved physical outcomes.", "[10] GPNMB ablation/vaccination improved selected mouse phenotypes and male progeroid survival.", "[11] DQ reduced aged adipose inflammation and improved metabolic outcomes, with weaker liver/muscle marker effects.", "[13] DQ delayed hearing decline in early-stage aging mice and modulated inflammatory signalling.", "[14] Multiomic p21/TREM2 macrophage profiling and senolysis linked a defined macrophage state to aged-liver dysfunction.", "[15] Monthly p21-high cell clearance beginning at 20 months improved mouse function and median/maximal survival.", "[16] DQ enhanced old-muscle regeneration but blunted young-muscle regeneration after injury.", "[17] DQ improved aged tibial endocortical loading response but not aged ulnar periosteal response.", "[18] Senolytics improved remyelination in young/middle-aged but not aged mice; CCL11 impaired maturation.", "[24] BCL-xL inhibition improved mouse diabetic retinal leakage; human phase 1 met safety objectives.", "[26] Clearing p16-positive cells did not rescue young-mouse ovariectomy bone loss; short human estrogen treatment did not change senescence markers.", "[28] TRM EP2 reduction improved efferocytosis and multiple aged-mouse functional outcomes.", "[29] Enhanced normally regulated Arf/p53 protected mice from damage and selected aging phenotypes.", "[30] Genetic and drug clearance improved function after bleomycin lung injury even when visible fibrosis remained.", "[31] Multimodal profiling localized aged-muscle states and a senotherapeutic improved mouse strength.", "[32] Knock-in p16-high clearance removed indispensable endothelial populations and worsened barriers, fibrosis and health.", "[33] p16-mediated PD-L1 stabilization promoted persistence and Fc-engaging antibodies cleared defined populations.", "[34] Canagliflozin promoted clearance-related immune changes and extended progeroid mouse life.", "[35] Clearance reduced hepatic fat and inducing hepatocyte senescence increased lipid accumulation.", "[36] Aged melanocyte secretome caused paracrine telomere dysfunction and epidermal-model atrophy reversible by intervention.", "[37] ABT263 cleared targeted populations and improved aged or irradiated stem-cell function.", "[38] Genetic and drug clearance improved metabolic, renal and cardiac outcomes in obese mice.", "[39] INK-ATTAC glial clearance prevented tau pathology, neuronal loss and cognitive decline in PS19 mice.", "[40] FOXO4-p53 interfering peptide restored selected functions in naturally aged and stressed/progeroid mice.", "[41] Clearance restored neurogenesis and reduced anxiety-related behavior in obese mice.", "[43] Genetic and DQ treatment reduced aged-microglial p16 state and improved mouse cognition.", "[44] Post-traumatic joint clearance reduced pain/pathology and improved cartilage-related outcomes.", "[45] HLA-E/NKG2A blockade enhanced immune recognition of cultured senescent cells; aged skin had higher HLA-E.", "[46] Clearance reduced atherosclerotic lesion development and instability-related phenotypes in Ldlr-null mice.", "[47] Telomere damage marked post-mitotic cardiomyocyte states and clearance reduced mouse hypertrophy/fibrosis.", "[48] Spatial profiling and p21-high clearance linked a wound-induced inflammatory population to slower closure.", "[49] p16-positive niche fibroblasts promoted epithelial lung regeneration and p16 was functionally required.", "[50] Inducible p21-Cre captured aged marker-high populations and clearance improved old-mouse function.", "[51] p16-3MR clearance reduced osteoclast-progenitor markers but did not prevent age-related bone loss.", "[52] Fisetin improved old-mouse vascular function, with nonadditive ex vivo genetic clearance supporting a senolytic route.", "[53] A beta-gal-activated prodrug reduced markers/inflammation and restored aged-mouse function.", "[54] p21-high clearance accelerated fracture repair but not aging bone loss; p16 clearance showed the converse boundary.", "[55] Aged skeletal stem-cell niche resisted youthful circulation; local BMP2/CSF1-antagonist combination restored regeneration.", "[57] Topical ABT263 primed old skin and accelerated later wound closure with transient inflammation.", "[58] Transient SASP exposure promoted regenerative plasticity whereas prolonged exposure induced arrest.", "[60] Survival-network targeting identified cell-type-dependent DQ senolysis and improved selected mouse functions.", "[61] Original Results show macrophage p16/beta-gal states respond reversibly to immune stimuli.", "[62] A 2026 p16-3MR reevaluation failed to reproduce reporter and ablation performance with wild-type controls." ], "what_would_cross_it": "" }, { "subclaim_id": "SC2", "threshold": "Ζ", "requirement_quoted": "Requires:\n- Reproducible intervention effects\n- Mechanistic narrowing\n- Evidence not reducible to general sickness, caloric reduction, or developmental artifacts", "satisfied": "no", "supporting_evidence": [ "[1] uPAR CAR-T cleared targeted cells and improved induced fibrosis or treated lung-cancer outcomes.", "[2] Adult INK-ATTAC clearance extended median life in both sexes and two mouse backgrounds with selected organ benefits.", "[3] Senescent-cell transfer impaired function; clearance rescued and late-life DQ increased median remaining survival.", "[4] INK-ATTAC clearance delayed selected pathologies in BubR1 progeroid mice, including late intervention.", "[5] Late-life fisetin reduced markers and improved mouse health and survival.", "[6] Itpr2 loss reduced senescence and improved mouse survival and metabolic phenotypes.", "[7] Several clearance strategies worsened pulmonary vascular remodeling and endothelial loss in defined models.", "[8] Old-donor heart transplantation induced recipient dysfunction; donor senolysis reduced mtDNA release and improved physical outcomes.", "[10] GPNMB ablation/vaccination improved selected mouse phenotypes and male progeroid survival.", "[11] DQ reduced aged adipose inflammation and improved metabolic outcomes, with weaker liver/muscle marker effects.", "[13] DQ delayed hearing decline in early-stage aging mice and modulated inflammatory signalling.", "[14] Multiomic p21/TREM2 macrophage profiling and senolysis linked a defined macrophage state to aged-liver dysfunction.", "[15] Monthly p21-high cell clearance beginning at 20 months improved mouse function and median/maximal survival.", "[16] DQ enhanced old-muscle regeneration but blunted young-muscle regeneration after injury.", "[17] DQ improved aged tibial endocortical loading response but not aged ulnar periosteal response.", "[18] Senolytics improved remyelination in young/middle-aged but not aged mice; CCL11 impaired maturation.", "[24] BCL-xL inhibition improved mouse diabetic retinal leakage; human phase 1 met safety objectives.", "[26] Clearing p16-positive cells did not rescue young-mouse ovariectomy bone loss; short human estrogen treatment did not change senescence markers.", "[28] TRM EP2 reduction improved efferocytosis and multiple aged-mouse functional outcomes.", "[29] Enhanced normally regulated Arf/p53 protected mice from damage and selected aging phenotypes.", "[30] Genetic and drug clearance improved function after bleomycin lung injury even when visible fibrosis remained.", "[31] Multimodal profiling localized aged-muscle states and a senotherapeutic improved mouse strength.", "[32] Knock-in p16-high clearance removed indispensable endothelial populations and worsened barriers, fibrosis and health.", "[33] p16-mediated PD-L1 stabilization promoted persistence and Fc-engaging antibodies cleared defined populations.", "[34] Canagliflozin promoted clearance-related immune changes and extended progeroid mouse life.", "[35] Clearance reduced hepatic fat and inducing hepatocyte senescence increased lipid accumulation.", "[36] Aged melanocyte secretome caused paracrine telomere dysfunction and epidermal-model atrophy reversible by intervention.", "[37] ABT263 cleared targeted populations and improved aged or irradiated stem-cell function.", "[38] Genetic and drug clearance improved metabolic, renal and cardiac outcomes in obese mice.", "[39] INK-ATTAC glial clearance prevented tau pathology, neuronal loss and cognitive decline in PS19 mice.", "[40] FOXO4-p53 interfering peptide restored selected functions in naturally aged and stressed/progeroid mice.", "[41] Clearance restored neurogenesis and reduced anxiety-related behavior in obese mice.", "[43] Genetic and DQ treatment reduced aged-microglial p16 state and improved mouse cognition.", "[44] Post-traumatic joint clearance reduced pain/pathology and improved cartilage-related outcomes.", "[45] HLA-E/NKG2A blockade enhanced immune recognition of cultured senescent cells; aged skin had higher HLA-E.", "[46] Clearance reduced atherosclerotic lesion development and instability-related phenotypes in Ldlr-null mice.", "[47] Telomere damage marked post-mitotic cardiomyocyte states and clearance reduced mouse hypertrophy/fibrosis.", "[48] Spatial profiling and p21-high clearance linked a wound-induced inflammatory population to slower closure.", "[49] p16-positive niche fibroblasts promoted epithelial lung regeneration and p16 was functionally required.", "[50] Inducible p21-Cre captured aged marker-high populations and clearance improved old-mouse function.", "[51] p16-3MR clearance reduced osteoclast-progenitor markers but did not prevent age-related bone loss.", "[52] Fisetin improved old-mouse vascular function, with nonadditive ex vivo genetic clearance supporting a senolytic route.", "[53] A beta-gal-activated prodrug reduced markers/inflammation and restored aged-mouse function.", "[54] p21-high clearance accelerated fracture repair but not aging bone loss; p16 clearance showed the converse boundary.", "[55] Aged skeletal stem-cell niche resisted youthful circulation; local BMP2/CSF1-antagonist combination restored regeneration.", "[57] Topical ABT263 primed old skin and accelerated later wound closure with transient inflammation.", "[58] Transient SASP exposure promoted regenerative plasticity whereas prolonged exposure induced arrest.", "[60] Survival-network targeting identified cell-type-dependent DQ senolysis and improved selected mouse functions.", "[61] Original Results show macrophage p16/beta-gal states respond reversibly to immune stimuli.", "[62] A 2026 p16-3MR reevaluation failed to reproduce reporter and ablation performance with wild-type controls." ], "what_would_cross_it": "Independent marker-agnostic lineage targeting, restorative rescue and replicated natural-aging functional effects narrowing cell and secretome mediation would support Ζ." }, { "subclaim_id": "SC3", "threshold": "Δ", "requirement_quoted": "Requires at least one intervention changing lifespan or healthspan in a way consistent with the hypothesis.", "satisfied": "yes", "supporting_evidence": [ "[2] Adult INK-ATTAC clearance extended median life in both sexes and two mouse backgrounds with selected organ benefits.", "[3] Senescent-cell transfer impaired function; clearance rescued and late-life DQ increased median remaining survival.", "[5] Late-life fisetin reduced markers and improved mouse health and survival.", "[6] Itpr2 loss reduced senescence and improved mouse survival and metabolic phenotypes.", "[10] GPNMB ablation/vaccination improved selected mouse phenotypes and male progeroid survival.", "[15] Monthly p21-high cell clearance beginning at 20 months improved mouse function and median/maximal survival.", "[22] The 60-person bone RCT missed its primary CTx endpoint and had transient secondary formation-marker changes.", "[23] The 12-person randomized IPF pilot completed dosing but showed no meaningful between-group functional signal.", "[24] BCL-xL inhibition improved mouse diabetic retinal leakage; human phase 1 met safety objectives.", "[34] Canagliflozin promoted clearance-related immune changes and extended progeroid mouse life." ], "what_would_cross_it": "" }, { "subclaim_id": "SC3", "threshold": "Ε", "requirement_quoted": "Requires causal effect in constrained contexts, backgrounds, or species.", "satisfied": "yes", "supporting_evidence": [ "[2] Adult INK-ATTAC clearance extended median life in both sexes and two mouse backgrounds with selected organ benefits.", "[3] Senescent-cell transfer impaired function; clearance rescued and late-life DQ increased median remaining survival.", "[5] Late-life fisetin reduced markers and improved mouse health and survival.", "[6] Itpr2 loss reduced senescence and improved mouse survival and metabolic phenotypes.", "[10] GPNMB ablation/vaccination improved selected mouse phenotypes and male progeroid survival.", "[15] Monthly p21-high cell clearance beginning at 20 months improved mouse function and median/maximal survival.", "[22] The 60-person bone RCT missed its primary CTx endpoint and had transient secondary formation-marker changes.", "[23] The 12-person randomized IPF pilot completed dosing but showed no meaningful between-group functional signal.", "[24] BCL-xL inhibition improved mouse diabetic retinal leakage; human phase 1 met safety objectives.", "[34] Canagliflozin promoted clearance-related immune changes and extended progeroid mouse life." ], "what_would_cross_it": "" }, { "subclaim_id": "SC3", "threshold": "Ζ", "requirement_quoted": "Requires:\n- Reproducible intervention effects\n- Mechanistic narrowing\n- Evidence not reducible to general sickness, caloric reduction, or developmental artifacts", "satisfied": "no", "supporting_evidence": [ "[2] Adult INK-ATTAC clearance extended median life in both sexes and two mouse backgrounds with selected organ benefits.", "[3] Senescent-cell transfer impaired function; clearance rescued and late-life DQ increased median remaining survival.", "[5] Late-life fisetin reduced markers and improved mouse health and survival.", "[6] Itpr2 loss reduced senescence and improved mouse survival and metabolic phenotypes.", "[10] GPNMB ablation/vaccination improved selected mouse phenotypes and male progeroid survival.", "[15] Monthly p21-high cell clearance beginning at 20 months improved mouse function and median/maximal survival.", "[22] The 60-person bone RCT missed its primary CTx endpoint and had transient secondary formation-marker changes.", "[23] The 12-person randomized IPF pilot completed dosing but showed no meaningful between-group functional signal.", "[24] BCL-xL inhibition improved mouse diabetic retinal leakage; human phase 1 met safety objectives.", "[34] Canagliflozin promoted clearance-related immune changes and extended progeroid mouse life." ], "what_would_cross_it": "Replicated survival plus meaningful functional trajectories across independent populations/modalities, with toxicity and intervention specificity resolved, would support Ζ; human efficacy requires a separate sufficiently powered clinical trial." } ], "generalization_check": { "generalization_tested": "yes", "context_boundary_mapped": "yes", "internal_negative_controls": [ "AP20187 did not improve survival in non-ATTAC mice.", "Young versus old repair and p16 versus p21 populations show different effects.", "Ovariectomy bone loss and unengaged osteocytes do not respond to particular clearance systems.", "Endothelial loss can worsen pulmonary vascular and hepatic-barrier outcomes." ], "note": "Mouse context boundaries are mapped across genetic backgrounds, sex, organ, marker construct and injury timing. Human samples and small randomized trials do not map a general functional-healthspan benefit." }, "falsification_patterns_met": [ { "pattern": "Clearance can harm structural or reparative populations", "evidence": "p16-high hepatic endothelium, pulmonary vascular models and lung sentinel fibroblasts; these reject untimed universal clearance benefit.", "downgrade_applied": false }, { "pattern": "Randomized functional or primary endpoint benefit absent", "evidence": "IPF feasibility RCT had no meaningful function signal; bone trial primary CTx was null. Low power and surrogate endpoints constrain interpretation.", "downgrade_applied": false } ], "pitfalls_flagged": [ { "pitfall": "Marker reduction mistaken for functional rejuvenation", "where": "Human DKD and SenMayo panels are separated from durable clinical benefit." }, { "pitfall": "Lifespan denominator inflation", "where": "Xu’s 36% is median remaining survival after old-age treatment, not a 36% increase in full lifespan." }, { "pitfall": "Reporter systems treated as interchangeable", "where": "INK-ATTAC, p16-3MR, knock-in p16-high and p21-Cre are distinguished." }, { "pitfall": "Concern notices ignored", "where": "PCC1 and PDGF-AA papers are flagged and do not support positive threshold crossings." }, { "pitfall": "Subgroup or shared-cohort evidence counted as replication", "where": "Bone-trial exploratory tertiles and biomarker reanalysis retain their provenance." } ], "causal_tally_audit": { "tally_claimed_by_document": 52, "tally_after_audit": 52, "items_rejected": [ "Null and negative contrasts are discriminators, not positive threshold crossings. Reports and replications are not independent causal lines.", "Shared cohorts, experimental platforms, transgenic lineages and repeated outcomes do not constitute fully independent causal lines." ] }, "steelman": { "case_one_rung_higher": "For SC2/SC3, Ζ is plausible given genetic and pharmacologic convergence. It is withheld because cell identity, construct scope and nonspecific drug effects remain unresolved, and most independent outcomes remain mouse or disease-specific. The bundled score cannot rise above Β by replacing its observational SC1 with another causal claim.", "case_one_rung_lower": "Γ for the defined mouse contribution would ignore adult clearance in two backgrounds, controlled transfer and orthogonal late-life p21 results. Α for the bundle would disregard reproducible multimarker age relationships.", "which_rejected": "Retain Β for the registered bundle, Ε for scoped mouse causality/application and Γ for human healthspan alone. These sensitivities are declared rather than allowed to silently replace the gate.", "blocking_cap_threshold_or_missing_experiment": "Missing experiment: Register independent-site adult clearance of a multimarker-defined cell lineage with orthogonal non-marker-dependent targeting, then restore the targeted cells or a specified SASP mediator; pair this with a powered randomized clinical trial using a prospectively defined tissue-burden stratum." }, "final_score": { "hsef_level": "Β", "hsef_descriptor": "Associational", "confidence": "Moderate", "confidence_rationale": "62 primary reports with 5 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness.", "rests_on_non_peer_reviewed_work": false, "rationale": "Preregistered weakest-link aggregation yields Β (SC1 Β, SC2 Ε, SC3 Ε). The causal-contribution sensitivity is Ε, not mere association. The application score acknowledges mouse survival and functional trajectories; human healthspan alone remains Γ. The bundled letter must not erase the causal contribution evidence or turn a real cellular state into a refuted phenomenon." }, "role_of_mechanism": { "classification": "reinforcing / stabilizing factor", "derivation_step_matched": 5, "derivation": "Senescent states arise after damage or repair, but transfer and clearance demonstrate feedback causal effects, so a purely downstream classification does not cover the scoped mechanism (steps 1–2). Clearance does not prevent all aging, rate limitation is unproved, and universal necessity is not shown (steps 3–4). Persistent defined populations amplify or maintain dysfunction, satisfying step 5, reinforcing / stabilizing factor.", "tournament_used_as_tiebreaker": false, "note": "Derived from causal direction, not tournament rank." }, "extended_scoring_MSD": { "momentum": { "value": "Decisive work underway", "artifact": "Late-life p21 clearance 2024, the bone RCT 2024, human biomarker reanalysis 2025, TRM clearance 2026 and reporter validation 2026 are named boundary tests in this corpus.", "justification": "Late-life p21 clearance 2024, the bone RCT 2024, human biomarker reanalysis 2025, TRM clearance 2026 and reporter validation 2026 are named boundary tests in this corpus." }, "stability": { "value": "Stable", "trigger": "No named pending result is asserted to be likely to move the registered score imminently.", "justification": "No named pending result is asserted to be likely to move the registered score imminently." }, "divergence": { "implied_level": null, "implied_level_basis": "No single field-implied level is defensible from conflicting framings.", "assessed_level": "Β", "gap_in_rungs": null, "value": "Contested", "justification": "No manufactured field consensus or arithmetic gap." }, "calibration_note": "M/S/D never modify HSEF level or confidence." }, "change_record": { "applies": false, "prior_level": "Ranking categorical verdict visible; no prior letter used as a target", "prior_confidence": null, "prior_source": null, "derived_before_consulting_prior": false, "new_level": "Β", "direction": "newly assigned", "what_moved_it": "Fresh primary evidence appraisal; not blinded.", "divergence_from_other_reviewers": null }, "proposed_decisive_experiments": [ { "name": "Registered boundary experiment", "experiment": "Register independent-site adult clearance of a multimarker-defined cell lineage with orthogonal non-marker-dependent targeting, then restore the targeted cells or a specified SASP mediator; pair this with a powered randomized clinical trial using a prospectively defined tissue-burden stratum.", "readout": "Longitudinal organ function, frailty and survival in naturally aged animals; prespecified durable patient function or disease endpoint rather than marker reduction alone", "critical_control": "Wild-type drug controls, sham transfer, cell identity/lineage validation, marker-negative clearance controls, sex/background replication, toxicity, mediator rescue and multiplicity-adjusted clinical endpoints", "supporting_result": "Selective removal plus rescue identifies the dysfunctional lineage/mediator and durable effects replicate independently", "falsifying_result": "Function changes without selective engagement, harm from structural loss, or a target-engaged powered human null" } ], "knowledge_gaps": [ { "name": "Gap 1", "statement": "Which distinct p16, p21 and marker-negative states mediate which dysfunctions, and how can irreversible senescence be distinguished from reversible immune activation?", "relevance": "Limits mechanism identification or scope." }, { "name": "Gap 2", "statement": "How general are the p16-3MR validation failure and the response, across colonies and original experimental contexts?", "relevance": "Limits mechanism identification or scope." }, { "name": "Gap 3", "statement": "Which harmful persistent populations can be removed while preserving endothelial structure, transient repair and tumour suppression?", "relevance": "Limits mechanism identification or scope." }, { "name": "Gap 4", "statement": "Can prospectively specified burden strata predict human benefit in an independent cohort after the current response-informed analyses?", "relevance": "Limits mechanism identification or scope." }, { "name": "Gap 5", "statement": "Do senolytic clinical effects depend on actual cell killing rather than kinase, metabolic or anti-inflammatory actions?", "relevance": "Limits mechanism identification or scope." }, { "name": "Gap 6", "statement": "How reproducible are lifespan and complete functional trajectories across independent sites and targets after concern-linked data are excluded?", "relevance": "Limits mechanism identification or scope." } ], "review_metadata": { "review_date": "2026-10-05", "reviewer": "Codex", "evidence_base_note": "62 primary reports; cutoff 2026-10-05; bounded critical review, not exhaustive systematic review.", "literature_tools_available": true, "literature_tools_note": "Life Sciences Literature PubMed/Europe PMC; signed-in Consensus browser discovery and attempted indexed full-text extraction. Successful passages and failures are reconciled with original sections where available; see case reconciliation. Zero Consensus API calls.", "skill_version": "5.3", "validator_run": "exact archived v5.3 validator 2.3; see validator.txt", "validator_warnings_addressed": "Phenomenon entry was restated as the preregistered causal claim. No real phenomenon is labelled refuted; warning is explicitly justified.", "consensus_consistency_audit": "2026-10-09; supplementary provenance/source reconciliation; original grading retained; prior grades visible." }, "is_calibration_entry": { "value": false, "entry_role": "not_calibration", "blind_graded": null, "completed_blinded_calibration": false, "expected_band_sealed_at": "", "target_sha256": "", "target_authorship": "not applicable", "target_author_saw_review": null, "future_run_status": "not prepared", "unblinded_reason": "Ranking categorical verdict and index guidance were visible. No completed blinded calibration claimed." }, "upper_ladder_check": { "final_level_below_zeta": true, "equivalents_considered": [ { "kind": "mendelian_randomization", "available": false, "why_not_sufficient": "Η and above remain reachable through convergent mechanisms and robust cross-context outcomes. Multiple mouse genetic/drug methods were considered. Shared marker identity, construct/platform reuse and drug pleiotropy limit convergence; human genetics, longitudinal tissue cohorts and clinical trials do not establish systemic aging primacy. Two concern-linked papers are excluded from threshold support." }, { "kind": "natural_experiment", "available": false, "why_not_sufficient": "Η and above remain reachable through convergent mechanisms and robust cross-context outcomes. Multiple mouse genetic/drug methods were considered. Shared marker identity, construct/platform reuse and drug pleiotropy limit convergence; human genetics, longitudinal tissue cohorts and clinical trials do not establish systemic aging primacy. Two concern-linked papers are excluded from threshold support." }, { "kind": "dose_response_across_populations", "available": false, "why_not_sufficient": "Η and above remain reachable through convergent mechanisms and robust cross-context outcomes. Multiple mouse genetic/drug methods were considered. Shared marker identity, construct/platform reuse and drug pleiotropy limit convergence; human genetics, longitudinal tissue cohorts and clinical trials do not establish systemic aging primacy. Two concern-linked papers are excluded from threshold support." }, { "kind": "withdrawal_rechallenge", "available": false, "why_not_sufficient": "Η and above remain reachable through convergent mechanisms and robust cross-context outcomes. Multiple mouse genetic/drug methods were considered. Shared marker identity, construct/platform reuse and drug pleiotropy limit convergence; human genetics, longitudinal tissue cohorts and clinical trials do not establish systemic aging primacy. Two concern-linked papers are excluded from threshold support." }, { "kind": "therapeutic_perturbation_hard_endpoint", "available": false, "why_not_sufficient": "Η and above remain reachable through convergent mechanisms and robust cross-context outcomes. Multiple mouse genetic/drug methods were considered. Shared marker identity, construct/platform reuse and drug pleiotropy limit convergence; human genetics, longitudinal tissue cohorts and clinical trials do not establish systemic aging primacy. Two concern-linked papers are excluded from threshold support." } ], "convergence_present": true, "cap_reapplied_to_convergent_set": false }, "provenance_header": { "sources_total": 62, "claims_total": 66, "claims_verified": 66, "claims_unverified": 0, "claims_contradicted": 0, "tier_a_sources": 62, "generated_by": "Codex; HSEF v5.3", "gate_passed": true }, "claims": [ { "id": "C1", "text": "uPAR CAR-T cleared targeted cells and improved induced fibrosis or treated lung-cancer outcomes. These are disease models, not normal-aging survival; a linked author correction remains to be resolved.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 1 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C2", "text": "Adult INK-ATTAC clearance extended median life in both sexes and two mouse backgrounds with selected organ benefits. Body text shows partial tissue clearance, variable maximal survival and several unchanged functional endpoints; other p16-positive cells may be affected.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2", "SC3" ], "source_ns": [ 2 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. Selected body sections: 6:Discussion:paragraph0, 7:METHODS:paragraph0, 7:METHODS:paragraph1, 1:ATTAC clears senescent adipocyte progenitor cells, 2:Clearance by ATTAC is partial and tissue selective, 3:p16Ink4a-positive cells shorten lifespan and healthspan. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C3", "text": "Senescent-cell transfer impaired function; clearance rescued and late-life DQ increased median remaining survival. Artificial transferred burden is not normal initiation; 36% refers to post-treatment survival, not whole lifespan, and drug pleiotropy remains.", "carries_number": false, "load_bearing_for": [ "SC2", "SC3" ], "source_ns": [ 3 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Results:paragraph15, 3:Online Methods:paragraph14, 1:Results:paragraph0, 1:Results:paragraph1, 1:Results:paragraph2, 1:Results:paragraph4, 1:Results:paragraph5, 1:Results:paragraph6. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C4", "text": "INK-ATTAC clearance delayed selected pathologies in BubR1 progeroid mice, including late intervention. A progeroid chromosome-checkpoint disorder does not represent the full spectrum of normal aging.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 4 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C5", "text": "Late-life fisetin reduced markers and improved mouse health and survival. Cell selectivity and drug pleiotropy limit causal attribution; human explants do not demonstrate clinical benefit.", "carries_number": false, "load_bearing_for": [ "SC2", "SC3" ], "source_ns": [ 5 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C6", "text": "Itpr2 loss reduced senescence and improved mouse survival and metabolic phenotypes. Calcium signalling and development are altered alongside senescence; clearance-mediated necessity is not isolated.", "carries_number": true, "load_bearing_for": [ "SC2", "SC3" ], "source_ns": [ 6 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C7", "text": "Several clearance strategies worsened pulmonary vascular remodeling and endothelial loss in defined models. Harm maps cell type and disease context, not absence of all beneficial senolytic effects.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 7 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C8", "text": "Old-donor heart transplantation induced recipient dysfunction; donor senolysis reduced mtDNA release and improved physical outcomes. Surgery and old-organ transfer are induced stressors; multiple donor changes complicate cell-specific mediation.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 8 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C9", "text": "The PCC1 original report described improved old-mouse function and survival. A 2026 editorial expression of concern identifies a similar control image and unavailable underlying raw data; no positive causal-threshold credit is assigned.", "carries_number": true, "load_bearing_for": [ "SC2", "SC3" ], "source_ns": [ 9 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C10", "text": "GPNMB ablation/vaccination improved selected mouse phenotypes and male progeroid survival. Antigen specificity and premature-aging survival do not establish general human antiaging efficacy.", "carries_number": false, "load_bearing_for": [ "SC2", "SC3" ], "source_ns": [ 10 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C11", "text": "DQ reduced aged adipose inflammation and improved metabolic outcomes, with weaker liver/muscle marker effects. Drug-mediated metabolism and cell elimination are incompletely separated; tissue responses are heterogeneous.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 11 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C12", "text": "IL-23R and other circulating/tissue signals tracked age and responded to several clearance approaches. A responsive biomarker does not uniquely count senescent cells or establish functional aging mediation.", "carries_number": true, "load_bearing_for": [ "SC1" ], "source_ns": [ 12 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C13", "text": "DQ delayed hearing decline in early-stage aging mice and modulated inflammatory signalling. NF-kappa-B binding provides a plausible non-senolytic action; strain-specific hearing loss restricts inference.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 13 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C14", "text": "Multiomic p21/TREM2 macrophage profiling and senolysis linked a defined macrophage state to aged-liver dysfunction. Human cirrhotic tissue is observational; macrophage activation and irreversible senescence need state-specific validation.", "carries_number": true, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 14 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C15", "text": "Monthly p21-high cell clearance beginning at 20 months improved mouse function and median/maximal survival. Marker-defined populations are heterogeneous; one mouse platform is not universal mammalian or human primacy.", "carries_number": true, "load_bearing_for": [ "SC2", "SC3" ], "source_ns": [ 15 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C16", "text": "DQ enhanced old-muscle regeneration but blunted young-muscle regeneration after injury. Age and repair timing determine effects; direct progenitor proliferation effects complicate senolysis mediation.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 16 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C17", "text": "DQ improved aged tibial endocortical loading response but not aged ulnar periosteal response. Bone surface, site and loading model define benefit; broad skeletal rejuvenation is unsupported.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 17 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C18", "text": "Senolytics improved remyelination in young/middle-aged but not aged mice; CCL11 impaired maturation. Old-age nonresponse and injury context constrain translation; preprint and published update are not independent reports.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 18 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C19", "text": "Nine kidney-disease participants had lower skin/adipose marker burden after short DQ treatment. Open-label biomarkers do not demonstrate renal functional benefit; linked corrigendum details remain unresolved.", "carries_number": false, "load_bearing_for": [ "SC1", "SC3" ], "source_ns": [ 19 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C20", "text": "Five AD participants completed feasibility treatment; dasatinib entered CSF but cognition/imaging did not significantly change. Uncontrolled small safety study is not an efficacy trial; quercetin was undetectable in CSF.", "carries_number": false, "load_bearing_for": [ "SC3" ], "source_ns": [ 20 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C21", "text": "Open-label IPF feasibility study reported improved walking/gait/chair measures but unchanged lung function. No placebo control and multiple secondary outcomes prevent attribution of human healthspan benefit.", "carries_number": false, "load_bearing_for": [ "SC3" ], "source_ns": [ 21 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C22", "text": "The 60-person bone RCT missed its primary CTx endpoint and had transient secondary formation-marker changes. High-p16 tertile benefits were exploratory; sustained clinical function and fracture reduction were not established.", "carries_number": true, "load_bearing_for": [ "SC3" ], "source_ns": [ 22 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C23", "text": "The 12-person randomized IPF pilot completed dosing but showed no meaningful between-group functional signal. Original Methods make feasibility/safety primary and report no multiplicity allowance; low power prevents definitive inefficacy inference.", "carries_number": true, "load_bearing_for": [ "SC3" ], "source_ns": [ 23 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Methods, 2:Results. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C24", "text": "BCL-xL inhibition improved mouse diabetic retinal leakage; human phase 1 met safety objectives. Safety and preclinical function do not establish randomized human efficacy or general healthspan.", "carries_number": true, "load_bearing_for": [ "SC2", "SC3" ], "source_ns": [ 24 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C25", "text": "T-cell p16 variants and a SASP panel refined an exploratory bone-trial responder association. Body text confirms reuse of the same trial and response-informed tertile analyses; this is not independent validation of efficacy.", "carries_number": true, "load_bearing_for": [ "SC1", "SC3" ], "source_ns": [ 25 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Methods:paragraph8, 2:Results:paragraph2, 2:Results:paragraph5, 2:Results:paragraph6. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C26", "text": "Clearing p16-positive cells did not rescue young-mouse ovariectomy bone loss; short human estrogen treatment did not change senescence markers. Estrogen-deficiency bone loss is distinct from age-related bone loss and is a boundary rather than universal clearance failure.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 26 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C27", "text": "SenMayo enrichment and single-cell analysis identified senescence-related tissue states and clearance-responsive panels. Gene-set expression is not uniquely irreversible arrest or proof of mechanistic clinical benefit; some input cohorts are reused.", "carries_number": false, "load_bearing_for": [ "SC1" ], "source_ns": [ 27 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C28", "text": "TRM EP2 reduction improved efferocytosis and multiple aged-mouse functional outcomes. Macrophage metabolism and immune clearance are intertwined; human tissue associations do not prove human aging mediation.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 28 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C29", "text": "Enhanced normally regulated Arf/p53 protected mice from damage and selected aging phenotypes. Tumour-suppressor signalling has broad functions; suppressing every senescence program cannot be assumed beneficial.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 29 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C30", "text": "Genetic and drug clearance improved function after bleomycin lung injury even when visible fibrosis remained. Early injury-model intervention is not reversal of established human IPF or normal-aging initiation.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 30 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C31", "text": "Multimodal profiling localized aged-muscle states and a senotherapeutic improved mouse strength. Human tissue evidence remains observational; myofiber senescent-like states differ from proliferative-cell arrest.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 31 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C32", "text": "Knock-in p16-high clearance removed indispensable endothelial populations and worsened barriers, fibrosis and health. Different reporter thresholds and cell coverage distinguish this system from INK-ATTAC; it does not negate all selected-cell clearance benefits.", "carries_number": true, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 32 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C33", "text": "p16-mediated PD-L1 stabilization promoted persistence and Fc-engaging antibodies cleared defined populations. Checkpoint-mediated clearance is a particular immune mechanism; global human aging causation remains untested.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 33 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C34", "text": "Canagliflozin promoted clearance-related immune changes and extended progeroid mouse life. Glucose, metabolism and immunosurveillance all change; normal human lifespan benefit cannot be assigned to senolysis.", "carries_number": false, "load_bearing_for": [ "SC2", "SC3" ], "source_ns": [ 34 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C35", "text": "Clearance reduced hepatic fat and inducing hepatocyte senescence increased lipid accumulation. Hepatic steatosis causality is narrower than organismal aging primacy; metabolic mediators remain multicomponent.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 35 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C36", "text": "Aged melanocyte secretome caused paracrine telomere dysfunction and epidermal-model atrophy reversible by intervention. Human skin sampling plus engineered culture is not an in vivo clinical aging-trajectory experiment.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 36 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C37", "text": "ABT263 cleared targeted populations and improved aged or irradiated stem-cell function. BCL-family inhibitors affect other cells; radiation injury and natural aging are separate tested contexts.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 37 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C38", "text": "Genetic and drug clearance improved metabolic, renal and cardiac outcomes in obese mice. Obesity-related dysfunction and normal-aging necessity are distinct scopes.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 38 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C39", "text": "INK-ATTAC glial clearance prevented tau pathology, neuronal loss and cognitive decline in PS19 mice. Preventive intervention in mutant-tau disease does not establish normal aging initiation or human senolytic efficacy.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 39 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C40", "text": "FOXO4-p53 interfering peptide restored selected functions in naturally aged and stressed/progeroid mice. Peptide specificity and disease rescue require independent replication before broad survival claims.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 40 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C41", "text": "Clearance restored neurogenesis and reduced anxiety-related behavior in obese mice. Obesity-specific behavioral mechanisms and a linked erratum constrain broad interpretation.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 41 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C42", "text": "Aged bone lineages had elevated multiple markers, including osteocyte telomere damage and chromatin changes. Cross-sectional multi-marker identity improves existence evidence but does not by itself show causal bone loss.", "carries_number": false, "load_bearing_for": [ "SC1" ], "source_ns": [ 42 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C43", "text": "Genetic and DQ treatment reduced aged-microglial p16 state and improved mouse cognition. Systemic and microglial effects are intertwined; aged-mouse cognition is not established human healthspan.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 43 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C44", "text": "Post-traumatic joint clearance reduced pain/pathology and improved cartilage-related outcomes. p16-3MR validation concerns require model-specific caution; orthogonal drug effects retain pleiotropy.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 44 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C45", "text": "HLA-E/NKG2A blockade enhanced immune recognition of cultured senescent cells; aged skin had higher HLA-E. Culture immune killing and tissue association do not prove human systemic aging mediation.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 45 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C46", "text": "Clearance reduced atherosclerotic lesion development and instability-related phenotypes in Ldlr-null mice. A lipid-driven disease model does not establish autonomous initiation of normal aging.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 46 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C47", "text": "Telomere damage marked post-mitotic cardiomyocyte states and clearance reduced mouse hypertrophy/fibrosis. Reduced specific pathology does not demonstrate global rejuvenation; post-mitotic senescence identity needs multiple features.", "carries_number": false, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 47 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C48", "text": "Spatial profiling and p21-high clearance linked a wound-induced inflammatory population to slower closure. This injury population differs from p16-high reparative cells and does not define all age-related senescence.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 48 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C49", "text": "p16-positive niche fibroblasts promoted epithelial lung regeneration and p16 was functionally required. Postnatal sentinel cells are a useful boundary, not necessarily the same state as chronic harmful senescent cells.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 49 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C50", "text": "Inducible p21-Cre captured aged marker-high populations and clearance improved old-mouse function. Marker-defined targeting does not encompass all senescence; platform follow-ups are not independent system validation.", "carries_number": true, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 50 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C51", "text": "p16-3MR clearance reduced osteoclast-progenitor markers but did not prevent age-related bone loss. Osteocytes were not eliminated; the null cannot falsify unengaged osteocyte-mediated pathology and reporter validation is disputed.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 51 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C52", "text": "Fisetin improved old-mouse vascular function, with nonadditive ex vivo genetic clearance supporting a senolytic route. Ex vivo nonadditivity is supportive rather than complete mediation; p16-3MR validation and drug pleiotropy limit certainty.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 52 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C53", "text": "A beta-gal-activated prodrug reduced markers/inflammation and restored aged-mouse function. Lysosomal activity is not senescence-exclusive and one pharmacologic platform does not establish broad specificity.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 53 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C54", "text": "p21-high clearance accelerated fracture repair but not aging bone loss; p16 clearance showed the converse boundary. Distinct injury and aging states defeat a universal single-marker interpretation; published and preprint records are one study.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 54 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C55", "text": "Aged skeletal stem-cell niche resisted youthful circulation; local BMP2/CSF1-antagonist combination restored regeneration. A multifactorial niche intervention does not isolate senescent-cell burden as sole causal driver.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 55 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C56", "text": "The original PDGF-AA report proposed reparative senescence and rescue of wound closure. A linked 2026 expression of concern is present; detailed notice content was not obtained, so this paper receives no causal-threshold credit.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 56 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C57", "text": "Topical ABT263 primed old skin and accelerated later wound closure with transient inflammation. Pretreatment and an induced local inflammatory response complicate attribution to cell removal alone.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 57 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C58", "text": "Transient SASP exposure promoted regenerative plasticity whereas prolonged exposure induced arrest. Exposure duration and injured tissues define scope; this is not a clinical senescent-cell delivery strategy.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 58 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C59", "text": "Ink4a/Arf increased in defined aged tissue compartments and correlated with pathology/CR responses. Expression is a marker association, not an exclusive cell count or causal aging proof.", "carries_number": true, "load_bearing_for": [ "SC1" ], "source_ns": [ 59 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C60", "text": "Survival-network targeting identified cell-type-dependent DQ senolysis and improved selected mouse functions. Different compounds target different cells; progeroid and radiation results must be separated from natural-aging benefit.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 60 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C61", "text": "Original Results show macrophage p16/beta-gal states respond reversibly to immune stimuli. Single markers cannot uniquely identify irreversible senescence; this does not invalidate multi-marker ATTAC evidence wholesale.", "carries_number": true, "load_bearing_for": [ "SC1", "SC2" ], "source_ns": [ 61 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. Selected body sections: 1:RESULTS:paragraph3, 1:RESULTS:paragraph4, 1:RESULTS:paragraph5, 1:RESULTS:paragraph6. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "C62", "text": "A 2026 p16-3MR reevaluation failed to reproduce reporter and ablation performance with wild-type controls. This targets a particular construct; INK-ATTAC is distinct, and an accompanying response exists but its substantive contents were unavailable.", "carries_number": true, "load_bearing_for": [ "SC2" ], "source_ns": [ 62 ], "verification": "verified", "verified_against": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "verified_on": "2026-10-05", "note": "" }, { "id": "CSC1", "text": "Multimarker and cell-resolved studies support accumulation in defined aged tissues. This age relationship remains observational and p16 alone is not exclusive.", "carries_number": false, "load_bearing_for": [ "SC1" ], "source_ns": [ 2, 12, 14, 19, 25, 27, 31, 32, 36, 42, 47, 50, 59, 61 ], "verification": "verified", "verified_against": "Synthesis of examined primary result/limit cards; framework level is adjudication.", "verified_on": "2026-10-05", "note": "" }, { "id": "CSC2", "text": "Selective adult clearance, transfer/clearance and orthogonal genetic/drug contrasts support causal contribution to defined mouse functions. Incomplete specificity, tissue-dependent harm and reporter concerns prevent universal necessity or systemic primacy.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 15, 16, 17, 18, 24, 26, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 60, 61, 62 ], "verification": "verified", "verified_against": "Synthesis of examined primary result/limit cards; framework level is adjudication.", "verified_on": "2026-10-05", "note": "" }, { "id": "CSC3", "text": "The disjunction is met in constrained mouse lifespan/healthspan settings, including adult p16 and late-life p21 clearance. Human durable functional benefit is a separate Γ sensitivity, not a condition silently added to the registered mammalian-or-human claim.", "carries_number": false, "load_bearing_for": [ "SC3" ], "source_ns": [ 2, 3, 5, 6, 9, 10, 15, 19, 20, 21, 22, 23, 24, 25, 34 ], "verification": "verified", "verified_against": "Synthesis of examined primary result/limit cards; framework level is adjudication.", "verified_on": "2026-10-05", "note": "" }, { "id": "CH", "text": "Senescent and marker-high cell populations causally contribute to defined mouse dysfunctions; durable human healthspan benefit remains unproved.", "carries_number": false, "load_bearing_for": [ "SC2" ], "source_ns": [ 2, 3, 15, 22, 23 ], "verification": "verified", "verified_against": "Bounded synthesis of examined sources; score is adjudication.", "verified_on": "2026-10-05", "note": "" } ], "citation_ledger": [ { "n": 1, "citation": "Amor C, Feucht J, Leibold J et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature. 2020.", "tier": "A", "kind": "primary", "pmid": "32555459", "doi": "10.1038/s41586-020-2403-9", "url": "https://pubmed.ncbi.nlm.nih.gov/32555459/", "status_flags": [ "ErratumIn: PMID38383793" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID32555459", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C1", "CSC2" ] }, { "n": 2, "citation": "Baker DJ, Childs BG, Durik M et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature. 2016.", "tier": "A", "kind": "primary", "pmid": "26840489", "doi": "10.1038/nature16932", "url": "https://pubmed.ncbi.nlm.nih.gov/26840489/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "INK-ATTAC lineage, two natural-aging cohorts", "access_depth": "full_text_partial", "access_note": "Complete primary abstract and linked-status metadata examined. Selected body sections: 6:Discussion:paragraph0, 7:METHODS:paragraph0, 7:METHODS:paragraph1, 1:ATTAC clears senescent adipocyte progenitor cells, 2:Clearance by ATTAC is partial and tissue selective, 3:p16Ink4a-positive cells shorten lifespan and healthspan. No complete-paper or supplement audit claimed.", "carries_claims": [ "C2", "CSC1", "CSC2", "CSC3", "CH" ] }, { "n": 3, "citation": "Xu M, Pirtskhalava T, Farr JN et al. Senolytics improve physical function and increase lifespan in old age. Nature medicine. 2018.", "tier": "A", "kind": "primary", "pmid": "29988130", "doi": "10.1038/s41591-018-0092-9", "url": "https://pubmed.ncbi.nlm.nih.gov/29988130/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "Xu transfer and aged-DQ experiments", "access_depth": "full_text_partial", "access_note": "Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Results:paragraph15, 3:Online Methods:paragraph14, 1:Results:paragraph0, 1:Results:paragraph1, 1:Results:paragraph2, 1:Results:paragraph4, 1:Results:paragraph5, 1:Results:paragraph6. No complete-paper or supplement audit claimed.", "carries_claims": [ "C3", "CSC2", "CSC3", "CH" ] }, { "n": 4, "citation": "Baker DJ, Wijshake T, Tchkonia T et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011.", "tier": "A", "kind": "primary", "pmid": "22048312", "doi": "10.1038/nature10600", "url": "https://pubmed.ncbi.nlm.nih.gov/22048312/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "INK-ATTAC lineage, BubR1 cohort", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C4", "CSC2" ] }, { "n": 5, "citation": "Yousefzadeh MJ, Zhu Y, McGowan SJ et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018.", "tier": "A", "kind": "primary", "pmid": "30279143", "doi": "10.1016/j.ebiom.2018.09.015", "url": "https://pubmed.ncbi.nlm.nih.gov/30279143/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID30279143", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C5", "CSC2", "CSC3" ] }, { "n": 6, "citation": "Ziegler DV, Vindrieux D, Goehrig D et al. Calcium channel ITPR2 and mitochondria-ER contacts promote cellular senescence and aging. Nature communications. 2021.", "tier": "A", "kind": "primary", "pmid": "33526781", "doi": "10.1038/s41467-021-20993-z", "url": "https://pubmed.ncbi.nlm.nih.gov/33526781/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID33526781", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C6", "CSC2", "CSC3" ] }, { "n": 7, "citation": "Born E, Lipskaia L, Breau M et al. Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression. Circulation. 2023.", "tier": "A", "kind": "primary", "pmid": "36515093", "doi": "10.1161/CIRCULATIONAHA.122.058794", "url": "https://pubmed.ncbi.nlm.nih.gov/36515093/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID36515093", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C7", "CSC2" ] }, { "n": 8, "citation": "Iske J, Roesel MJ, Martin F et al. Transplanting old organs promotes senescence in young recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2024.", "tier": "A", "kind": "primary", "pmid": "37913871", "doi": "10.1016/j.ajt.2023.10.013", "url": "https://pubmed.ncbi.nlm.nih.gov/37913871/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID37913871", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C8", "CSC2" ] }, { "n": 9, "citation": "Xu Q, Fu Q, Li Z et al. The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice. Nature metabolism. 2021.", "tier": "A", "kind": "primary", "pmid": "34873338", "doi": "10.1038/s42255-021-00491-8", "url": "https://pubmed.ncbi.nlm.nih.gov/34873338/", "status_flags": [ "ExpressionOfConcernIn: PMID41731120" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID34873338", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C9", "CSC2", "CSC3" ] }, { "n": 10, "citation": "Suda M, Shimizu I, Katsuumi G et al. Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice. Nature aging. 2021.", "tier": "A", "kind": "primary", "pmid": "37117524", "doi": "10.1038/s43587-021-00151-2", "url": "https://pubmed.ncbi.nlm.nih.gov/37117524/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID37117524", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C10", "CSC2", "CSC3" ] }, { "n": 11, "citation": "Islam MT, Tuday E, Allen S et al. Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age. Aging cell. 2023.", "tier": "A", "kind": "primary", "pmid": "36637079", "doi": "10.1111/acel.13767", "url": "https://pubmed.ncbi.nlm.nih.gov/36637079/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID36637079", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C11", "CSC2" ] }, { "n": 12, "citation": "Carver CM, Rodriguez SL, Atkinson EJ et al. IL-23R is a senescence-linked circulating and tissue biomarker of aging. Nature aging. 2025.", "tier": "A", "kind": "primary", "pmid": "39658621", "doi": "10.1038/s43587-024-00752-7", "url": "https://pubmed.ncbi.nlm.nih.gov/39658621/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID39658621", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C12", "CSC1" ] }, { "n": 13, "citation": "Chen Y, Huang H, Luo Y et al. Senolytic treatment alleviates cochlear senescence and delays age-related hearing loss in C57BL/6J mice. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2025.", "tier": "A", "kind": "primary", "pmid": "40253743", "doi": "10.1016/j.phymed.2025.156772", "url": "https://pubmed.ncbi.nlm.nih.gov/40253743/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID40253743", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C13", "CSC2" ] }, { "n": 14, "citation": "Salladay-Perez IA, Avila I, Estrada L et al. p21+TREM2+ senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease. Nature aging. 2026.", "tier": "A", "kind": "primary", "pmid": "41991686", "doi": "10.1038/s43587-026-01101-6", "url": "https://pubmed.ncbi.nlm.nih.gov/41991686/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID41991686", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C14", "CSC1", "CSC2" ] }, { "n": 15, "citation": "Wang B, Wang L, Gasek NS et al. Intermittent clearance of p21-highly-expressing cells extends lifespan and confers sustained benefits to health and physical function. Cell metabolism. 2024.", "tier": "A", "kind": "primary", "pmid": "39111286", "doi": "10.1016/j.cmet.2024.07.006", "url": "https://pubmed.ncbi.nlm.nih.gov/39111286/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "p21-Cre platform, late-life survival cohort", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C15", "CSC2", "CSC3", "CH" ] }, { "n": 16, "citation": "Dungan CM, Murach KA, Zdunek CJ et al. Deletion of SA β-Gal+ cells using senolytics improves muscle regeneration in old mice. Aging cell. 2022.", "tier": "A", "kind": "primary", "pmid": "34904366", "doi": "10.1111/acel.13528", "url": "https://pubmed.ncbi.nlm.nih.gov/34904366/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID34904366", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C16", "CSC2" ] }, { "n": 17, "citation": "Cunningham CJ, Kok HJ, Farr JN et al. Senolytic Treatment Improves Responsiveness to Mechanical Loading in the Skeleton of Aged Mice. International journal of molecular sciences. 2025.", "tier": "A", "kind": "primary", "pmid": "41303716", "doi": "10.3390/ijms262211233", "url": "https://pubmed.ncbi.nlm.nih.gov/41303716/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID41303716", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C17", "CSC2" ] }, { "n": 18, "citation": "Gross PS, Durán-Laforet V, Ho LT et al. Senescent-like microglia limit remyelination through the senescence associated secretory phenotype. Nature communications. 2025.", "tier": "A", "kind": "primary", "pmid": "40055369", "doi": "10.1038/s41467-025-57632-w", "url": "https://pubmed.ncbi.nlm.nih.gov/40055369/", "status_flags": [ "UpdateOf: PMID38826296" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID40055369", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C18", "CSC2" ] }, { "n": 19, "citation": "Hickson LJ, Langhi Prata LGP, Bobart SA et al. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019.", "tier": "A", "kind": "primary", "pmid": "31542391", "doi": "10.1016/j.ebiom.2019.08.069", "url": "https://pubmed.ncbi.nlm.nih.gov/31542391/", "status_flags": [ "ErratumIn: PMID31982828" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID31542391", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C19", "CSC1", "CSC3" ] }, { "n": 20, "citation": "Gonzales MM, Garbarino VR, Kautz TF et al. Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial. Nature medicine. 2023.", "tier": "A", "kind": "primary", "pmid": "37679434", "doi": "10.1038/s41591-023-02543-w", "url": "https://pubmed.ncbi.nlm.nih.gov/37679434/", "status_flags": [ "UpdateOf: PMID37162971" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID37679434", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C20", "CSC3" ] }, { "n": 21, "citation": "Justice JN, Nambiar AM, Tchkonia T et al. Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine. 2019.", "tier": "A", "kind": "primary", "pmid": "30616998", "doi": "10.1016/j.ebiom.2018.12.052", "url": "https://pubmed.ncbi.nlm.nih.gov/30616998/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "IPF NCT02874989 open-label cohort", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C21", "CSC3" ] }, { "n": 22, "citation": "Farr JN, Atkinson EJ, Achenbach SJ et al. Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial. Nature medicine. 2024.", "tier": "A", "kind": "rct", "pmid": "38956196", "doi": "10.1038/s41591-024-03096-2", "url": "https://pubmed.ncbi.nlm.nih.gov/38956196/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "Bone NCT04313634", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C22", "CSC3", "CH" ] }, { "n": 23, "citation": "Nambiar A, Kellogg D, Justice J et al. Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability. EBioMedicine. 2023.", "tier": "A", "kind": "rct", "pmid": "36857968", "doi": "10.1016/j.ebiom.2023.104481", "url": "https://pubmed.ncbi.nlm.nih.gov/36857968/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "IPF NCT02874989 separate randomized cohort", "access_depth": "full_text_partial", "access_note": "Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Methods, 2:Results. No complete-paper or supplement audit claimed.", "carries_claims": [ "C23", "CSC3", "CH" ] }, { "n": 24, "citation": "Crespo-Garcia S, Fournier F, Diaz-Marin R et al. Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results. Nature medicine. 2024.", "tier": "A", "kind": "primary", "pmid": "38321220", "doi": "10.1038/s41591-024-02802-4", "url": "https://pubmed.ncbi.nlm.nih.gov/38321220/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID38321220", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C24", "CSC2", "CSC3" ] }, { "n": 25, "citation": "Farr JN, Monroe DG, Atkinson EJ et al. Characterization of Human Senescent Cell Biomarkers for Clinical Trials. Aging cell. 2025.", "tier": "A", "kind": "rct", "pmid": "39823170", "doi": "10.1111/acel.14489", "url": "https://pubmed.ncbi.nlm.nih.gov/39823170/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "Bone NCT04313634", "access_depth": "full_text_partial", "access_note": "Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Methods:paragraph8, 2:Results:paragraph2, 2:Results:paragraph5, 2:Results:paragraph6. No complete-paper or supplement audit claimed.", "carries_claims": [ "C25", "CSC1", "CSC3" ] }, { "n": 26, "citation": "Farr JN, Rowsey JL, Eckhardt BA et al. Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2019.", "tier": "A", "kind": "primary", "pmid": "30913313", "doi": "10.1002/jbmr.3729", "url": "https://pubmed.ncbi.nlm.nih.gov/30913313/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID30913313", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C26", "CSC2" ] }, { "n": 27, "citation": "Saul D, Kosinsky RL, Atkinson EJ et al. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nature communications. 2022.", "tier": "A", "kind": "primary", "pmid": "35974106", "doi": "10.1038/s41467-022-32552-1", "url": "https://pubmed.ncbi.nlm.nih.gov/35974106/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "SenMayo reused input cohorts; not independent efficacy", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C27", "CSC1" ] }, { "n": 28, "citation": "Tan YJ, Conley TE, Yao F et al. Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging. Science (New York, N.Y.). 2026.", "tier": "A", "kind": "primary", "pmid": "42462036", "doi": "10.1126/science.aea3075", "url": "https://pubmed.ncbi.nlm.nih.gov/42462036/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID42462036", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C28", "CSC2" ] }, { "n": 29, "citation": "Matheu A, Maraver A, Klatt P et al. Delayed ageing through damage protection by the Arf/p53 pathway. Nature. 2007.", "tier": "A", "kind": "primary", "pmid": "17637672", "doi": "10.1038/nature05949", "url": "https://pubmed.ncbi.nlm.nih.gov/17637672/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID17637672", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C29", "CSC2" ] }, { "n": 30, "citation": "Schafer MJ, White TA, Iijima K et al. Cellular senescence mediates fibrotic pulmonary disease. Nature communications. 2017.", "tier": "A", "kind": "primary", "pmid": "28230051", "doi": "10.1038/ncomms14532", "url": "https://pubmed.ncbi.nlm.nih.gov/28230051/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID28230051", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C30", "CSC2" ] }, { "n": 31, "citation": "Zhang X, Habiballa L, Aversa Z et al. Characterization of cellular senescence in aging skeletal muscle. Nature aging. 2022.", "tier": "A", "kind": "primary", "pmid": "36147777", "doi": "10.1038/s43587-022-00250-8", "url": "https://pubmed.ncbi.nlm.nih.gov/36147777/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID36147777", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C31", "CSC1", "CSC2" ] }, { "n": 32, "citation": "Grosse L, Wagner N, Emelyanov A et al. Defined p16High Senescent Cell Types Are Indispensable for Mouse Healthspan. Cell metabolism. 2020.", "tier": "A", "kind": "primary", "pmid": "32485135", "doi": "10.1016/j.cmet.2020.05.002", "url": "https://pubmed.ncbi.nlm.nih.gov/32485135/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID32485135", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C32", "CSC1", "CSC2" ] }, { "n": 33, "citation": "Majewska J, Agrawal A, Mayo A et al. p16-dependent increase of PD-L1 stability regulates immunosurveillance of senescent cells. Nature cell biology. 2024.", "tier": "A", "kind": "primary", "pmid": "39103548", "doi": "10.1038/s41556-024-01465-0", "url": "https://pubmed.ncbi.nlm.nih.gov/39103548/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID39103548", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C33", "CSC2" ] }, { "n": 34, "citation": "Katsuumi G, Shimizu I, Suda M et al. SGLT2 inhibition eliminates senescent cells and alleviates pathological aging. Nature aging. 2024.", "tier": "A", "kind": "primary", "pmid": "38816549", "doi": "10.1038/s43587-024-00642-y", "url": "https://pubmed.ncbi.nlm.nih.gov/38816549/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID38816549", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C34", "CSC2", "CSC3" ] }, { "n": 35, "citation": "Ogrodnik M, Miwa S, Tchkonia T et al. Cellular senescence drives age-dependent hepatic steatosis. Nature communications. 2017.", "tier": "A", "kind": "primary", "pmid": "28608850", "doi": "10.1038/ncomms15691", "url": "https://pubmed.ncbi.nlm.nih.gov/28608850/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID28608850", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C35", "CSC2" ] }, { "n": 36, "citation": "Victorelli S, Lagnado A, Halim J et al. Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction. The EMBO journal. 2019.", "tier": "A", "kind": "primary", "pmid": "31633821", "doi": "10.15252/embj.2019101982", "url": "https://pubmed.ncbi.nlm.nih.gov/31633821/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID31633821", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C36", "CSC1", "CSC2" ] }, { "n": 37, "citation": "Chang J, Wang Y, Shao L et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nature medicine. 2016.", "tier": "A", "kind": "primary", "pmid": "26657143", "doi": "10.1038/nm.4010", "url": "https://pubmed.ncbi.nlm.nih.gov/26657143/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID26657143", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C37", "CSC2" ] }, { "n": 38, "citation": "Palmer AK, Xu M, Zhu Y et al. Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Aging cell. 2019.", "tier": "A", "kind": "primary", "pmid": "30907060", "doi": "10.1111/acel.12950", "url": "https://pubmed.ncbi.nlm.nih.gov/30907060/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID30907060", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C38", "CSC2" ] }, { "n": 39, "citation": "Bussian TJ, Aziz A, Meyer CF et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature. 2018.", "tier": "A", "kind": "primary", "pmid": "30232451", "doi": "10.1038/s41586-018-0543-y", "url": "https://pubmed.ncbi.nlm.nih.gov/30232451/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID30232451", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C39", "CSC2" ] }, { "n": 40, "citation": "Baar MP, Brandt RMC, Putavet DA et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. 2017.", "tier": "A", "kind": "primary", "pmid": "28340339", "doi": "10.1016/j.cell.2017.02.031", "url": "https://pubmed.ncbi.nlm.nih.gov/28340339/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID28340339", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C40", "CSC2" ] }, { "n": 41, "citation": "Ogrodnik M, Zhu Y, Langhi LGP et al. Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis. Cell metabolism. 2019.", "tier": "A", "kind": "primary", "pmid": "30612898", "doi": "10.1016/j.cmet.2018.12.008", "url": "https://pubmed.ncbi.nlm.nih.gov/30612898/", "status_flags": [ "ErratumIn: PMID31067450" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID30612898", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C41", "CSC2" ] }, { "n": 42, "citation": "Farr JN, Fraser DG, Wang H et al. Identification of Senescent Cells in the Bone Microenvironment. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2016.", "tier": "A", "kind": "primary", "pmid": "27341653", "doi": "10.1002/jbmr.2892", "url": "https://pubmed.ncbi.nlm.nih.gov/27341653/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID27341653", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C42", "CSC1" ] }, { "n": 43, "citation": "Ogrodnik M, Evans SA, Fielder E et al. Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice. Aging cell. 2021.", "tier": "A", "kind": "primary", "pmid": "33470505", "doi": "10.1111/acel.13296", "url": "https://pubmed.ncbi.nlm.nih.gov/33470505/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID33470505", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C43", "CSC2" ] }, { "n": 44, "citation": "Jeon OH, Kim C, Laberge RM et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nature medicine. 2017.", "tier": "A", "kind": "primary", "pmid": "28436958", "doi": "10.1038/nm.4324", "url": "https://pubmed.ncbi.nlm.nih.gov/28436958/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID28436958", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C44", "CSC2" ] }, { "n": 45, "citation": "Pereira BI, Devine OP, Vukmanovic-Stejic M et al. Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition. Nature communications. 2019.", "tier": "A", "kind": "primary", "pmid": "31160572", "doi": "10.1038/s41467-019-10335-5", "url": "https://pubmed.ncbi.nlm.nih.gov/31160572/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID31160572", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C45", "CSC2" ] }, { "n": 46, "citation": "Childs BG, Baker DJ, Wijshake T et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science (New York, N.Y.). 2016.", "tier": "A", "kind": "primary", "pmid": "27789842", "doi": "10.1126/science.aaf6659", "url": "https://pubmed.ncbi.nlm.nih.gov/27789842/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID27789842", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C46", "CSC2" ] }, { "n": 47, "citation": "Anderson R, Lagnado A, Maggiorani D et al. Length-independent telomere damage drives post-mitotic cardiomyocyte senescence. The EMBO journal. 2019.", "tier": "A", "kind": "primary", "pmid": "30737259", "doi": "10.15252/embj.2018100492", "url": "https://pubmed.ncbi.nlm.nih.gov/30737259/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID30737259", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C47", "CSC1", "CSC2" ] }, { "n": 48, "citation": "Gasek NS, Yan P, Zhu J et al. Clearance of p21 highly expressing senescent cells accelerates cutaneous wound healing. Nature aging. 2025.", "tier": "A", "kind": "primary", "pmid": "39537987", "doi": "10.1038/s43587-024-00755-4", "url": "https://pubmed.ncbi.nlm.nih.gov/39537987/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "p21-Cre platform, wound cohort", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C48", "CSC2" ] }, { "n": 49, "citation": "Reyes NS, Krasilnikov M, Allen NC et al. Sentinel p16INK4a+ cells in the basement membrane form a reparative niche in the lung. Science (New York, N.Y.). 2022.", "tier": "A", "kind": "primary", "pmid": "36227993", "doi": "10.1126/science.abf3326", "url": "https://pubmed.ncbi.nlm.nih.gov/36227993/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID36227993", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C49", "CSC2" ] }, { "n": 50, "citation": "Wang B, Wang L, Gasek NS et al. An inducible p21-Cre mouse model to monitor and manipulate p21-highly-expressing senescent cells in vivo. Nature aging. 2021.", "tier": "A", "kind": "primary", "pmid": "35024619", "doi": "10.1038/s43587-021-00107-6", "url": "https://pubmed.ncbi.nlm.nih.gov/35024619/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "p21-Cre platform", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C50", "CSC1", "CSC2" ] }, { "n": 51, "citation": "Kim HN, Chang J, Iyer S et al. Elimination of senescent osteoclast progenitors has no effect on the age-associated loss of bone mass in mice. Aging cell. 2019.", "tier": "A", "kind": "primary", "pmid": "30773784", "doi": "10.1111/acel.12923", "url": "https://pubmed.ncbi.nlm.nih.gov/30773784/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID30773784", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C51", "CSC2" ] }, { "n": 52, "citation": "Mahoney SA, Venkatasubramanian R, Darrah MA et al. Intermittent supplementation with fisetin improves arterial function in old mice by decreasing cellular senescence. Aging cell. 2024.", "tier": "A", "kind": "primary", "pmid": "38062873", "doi": "10.1111/acel.14060", "url": "https://pubmed.ncbi.nlm.nih.gov/38062873/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID38062873", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C52", "CSC2" ] }, { "n": 53, "citation": "Cai Y, Zhou H, Zhu Y et al. Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice. Cell research. 2020.", "tier": "A", "kind": "primary", "pmid": "32341413", "doi": "10.1038/s41422-020-0314-9", "url": "https://pubmed.ncbi.nlm.nih.gov/32341413/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID32341413", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C53", "CSC2" ] }, { "n": 54, "citation": "Saul D, Doolittle ML, Rowsey JL et al. Osteochondroprogenitor cells and neutrophils expressing p21 and senescence markers modulate fracture repair. The Journal of clinical investigation. 2024.", "tier": "A", "kind": "primary", "pmid": "38753433", "doi": "10.1172/JCI179834", "url": "https://pubmed.ncbi.nlm.nih.gov/38753433/", "status_flags": [ "UpdateOf: PMID38370844" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "p21 fracture platform; published update", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C54", "CSC2" ] }, { "n": 55, "citation": "Ambrosi TH, Marecic O, McArdle A et al. Aged skeletal stem cells generate an inflammatory degenerative niche. Nature. 2021.", "tier": "A", "kind": "primary", "pmid": "34381212", "doi": "10.1038/s41586-021-03795-7", "url": "https://pubmed.ncbi.nlm.nih.gov/34381212/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID34381212", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C55", "CSC2" ] }, { "n": 56, "citation": "Demaria M, Ohtani N, Youssef SA et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Developmental cell. 2014.", "tier": "A", "kind": "primary", "pmid": "25499914", "doi": "10.1016/j.devcel.2014.11.012", "url": "https://pubmed.ncbi.nlm.nih.gov/25499914/", "status_flags": [ "ExpressionOfConcernIn: PMID42412492" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID25499914", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C56", "CSC2" ] }, { "n": 57, "citation": "Shvedova M, Thanapaul RJRS, Ha J et al. Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing. Aging. 2024.", "tier": "A", "kind": "primary", "pmid": "39630941", "doi": "10.18632/aging.206165", "url": "https://pubmed.ncbi.nlm.nih.gov/39630941/", "status_flags": [ "UpdateOf: PMID39229113" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID39630941", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C57", "CSC2" ] }, { "n": 58, "citation": "Ritschka B, Storer M, Mas A et al. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes & development. 2017.", "tier": "A", "kind": "primary", "pmid": "28143833", "doi": "10.1101/gad.290635.116", "url": "https://pubmed.ncbi.nlm.nih.gov/28143833/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID28143833", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C58", "CSC2" ] }, { "n": 59, "citation": "Krishnamurthy J, Torrice C, Ramsey MR et al. Ink4a/Arf expression is a biomarker of aging. The Journal of clinical investigation. 2004.", "tier": "A", "kind": "primary", "pmid": "15520862", "doi": "10.1172/JCI22475", "url": "https://pubmed.ncbi.nlm.nih.gov/15520862/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID15520862", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C59", "CSC1" ] }, { "n": 60, "citation": "Zhu Y, Tchkonia T, Pirtskhalava T et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging cell. 2015.", "tier": "A", "kind": "primary", "pmid": "25754370", "doi": "10.1111/acel.12344", "url": "https://pubmed.ncbi.nlm.nih.gov/25754370/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID25754370", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C60", "CSC2" ] }, { "n": 61, "citation": "Hall BM, Balan V, Gleiberman AS et al. p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli. Aging. 2017.", "tier": "A", "kind": "primary", "pmid": "28768895", "doi": "10.18632/aging.101268", "url": "https://pubmed.ncbi.nlm.nih.gov/28768895/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID28768895", "access_depth": "full_text_partial", "access_note": "Complete primary abstract and linked-status metadata examined. Selected body sections: 1:RESULTS:paragraph3, 1:RESULTS:paragraph4, 1:RESULTS:paragraph5, 1:RESULTS:paragraph6. No complete-paper or supplement audit claimed.", "carries_claims": [ "C61", "CSC1", "CSC2" ] }, { "n": 62, "citation": "Hori N, Kawamoto S, Uemura K et al. Limitations of the p16-3MR mouse model for detecting and eliminating senescent cells. EMBO reports. 2026.", "tier": "A", "kind": "primary", "pmid": "42209826", "doi": "10.1038/s44319-026-00802-8", "url": "https://pubmed.ncbi.nlm.nih.gov/42209826/", "status_flags": [ "none_found" ], "opened": true, "opened_on": "2026-10-05", "status_checked_on": "2026-10-05", "study_id": "PMID42209826", "access_depth": "abstract_metadata", "access_note": "Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed.", "carries_claims": [ "C62", "CSC2" ] } ], "independence_basis": { "required": false, "lines": [ { "label": "Timed genetic clearance", "sources": [ 2, 15 ], "excludes_error": "Reduces drug-only explanations; different markers still require identity controls." }, { "label": "Transfer with control cells and clearance", "sources": [ 3 ], "excludes_error": "Tests sufficiency and rejection alternatives; artificial burden remains." }, { "label": "Independent pharmacologic targets", "sources": [ 37, 40, 53 ], "excludes_error": "Reduces dependence on one compound; shared incomplete specificity persists." }, { "label": "Human randomized translation", "sources": [ 22, 23 ], "excludes_error": "Reduces uncontrolled practice/regression effects; power and endpoints remain limited." } ], "shared_failure_mode_checked": true, "note": "These lines address different errors but cannot be counted as universal independent proof. INK-ATTAC follow-ups share a construct; p21 reports share a platform. IPF open-label and randomized subjects are distinct within one trial program; bone biomarker reanalysis reuses the original participants." }, "consensus_validation": { "completed": true, "status": "documented_historical_discovery_and_reconciliation", "provider": "Consensus", "provider_mode": "Historical browser/connector use as recorded in the source artifacts", "local_audit_date": "2026-10-09", "primary_comparison_count": null, "reported_usage": [], "grade_changed": false, "score_before": { "hsef_level": "Β", "hsef_descriptor": "Associational", "confidence": "Moderate", "confidence_rationale": "62 primary reports with 5 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness.", "rests_on_non_peer_reviewed_work": false, "rationale": "Preregistered weakest-link aggregation yields Β (SC1 Β, SC2 Ε, SC3 Ε). The causal-contribution sensitivity is Ε, not mere association. The application score acknowledges mouse survival and functional trajectories; human healthspan alone remains Γ. The bundled letter must not erase the causal contribution evidence or turn a real cellular state into a refuted phenomenon." }, "score_after": { "hsef_level": "Β", "hsef_descriptor": "Associational", "confidence": "Moderate", "confidence_rationale": "62 primary reports with 5 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness.", "rests_on_non_peer_reviewed_work": false, "rationale": "Preregistered weakest-link aggregation yields Β (SC1 Β, SC2 Ε, SC3 Ε). The causal-contribution sensitivity is Ε, not mere association. The application score acknowledges mouse survival and functional trajectories; human healthspan alone remains Γ. The bundled letter must not erase the causal contribution evidence or turn a real cellular state into a refuted phenomenon." }, "independent_blinded_audit": false, "raw_receipts": [ { "path": "deliverables\\hsef_v53_popularity_ranks_11_15_2026-10-05\\senescence-aging-driver\\consensus\\completed-dom.txt", "sha256": "f0d5d7ea9a4eb22fb19ca73596b497855b8b18c464cdb9c108925211b580b62f" }, { "path": "deliverables\\hsef_v53_popularity_ranks_11_15_2026-10-05\\senescence-aging-driver\\consensus\\deep-response.txt", "sha256": "79851038f7577d046433845fd0ec11d564ab093b6439f9ebc89f06f8f0a77319" }, { "path": "deliverables\\hsef_v53_popularity_ranks_11_15_2026-10-05\\senescence-aging-driver\\consensus\\pro-response.txt", "sha256": "c613154f68681225ed39b8ef11de7e4a84428ff37c8eff145a333c6d30c2d713" }, { "path": "deliverables\\hsef_v53_popularity_ranks_11_15_2026-10-05\\senescence-aging-driver\\consensus\\pro-screenshot.png", "sha256": "2d9d61384fc286450e47aa1db26e7aeb372183a7b3a80b0c16c5b7d2f21667c7" }, { "path": "deliverables\\hsef_v53_popularity_ranks_11_15_2026-10-05\\senescence-aging-driver\\consensus\\provenance.json", "sha256": "95ced0d68bc6e545a56232c1edcb3527e9a6dca9a7c3e05a5fa65c8db7f78b5a" } ], "limitations": "This verifies documented historical use and links the record to the final edition. It adds no primary-source, full-text, independence or verification credit. Original access remains limited to the source-specific record." } }